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The intervertebral disc (IVD) is a cartilaginous structure in the spinal column 
comprised of the inner nucleus pulposus (NP) and the outer annulus fibrosus (AF). 
With untreated damage to the AF, the pressure forces the nucleus out into the 
surrounding disc space causing pain and, eventually, degenerative disc disease (DDD).  
Once an IVD has fully degenerated, treatment options are limited to full disc 
replacement or spinal fusion, and as such, research groups have begun to develop 
methods for tissue engineering repair and regeneration of damaged IVDs including 
repair of defects in the AF.  This study evaluates an injectable, photocrosslinkable 
collagen hydrogel for the mechanical and biological repair of annulus fibrosus defects. 
Collagen hydrogels for biomedical applications are often limited due their 
weak bulk mechanical properties. In order to increase their mechanical strength, 
researchers can increase the density of collagen in the final gel, crosslink the fibers of 
the resulting collagen gel, or both.  The first aim observed the effects of collagen gels 
at different densities and degrees of riboflavin crosslinking on the repair of annulus 
fibrosus defects of different sizes in an in vitro rat caudal AF repair model.  We 
observed improvements in the effective mechanical behavior of damaged IVDs with 
increasing collagen density and riboflavin concentration.   
After establishing the collagen gel as a possible AF repair technology 
mechanically, we transitioned from an in vitro model to an in vivo, rat caudal model of 
annular repair to better assess biological healing.  The second aim centered on the use 
of both uncrosslinkined and crosslinked collagen gel formulations from aim 1 in an in 
vivo rat tail puncture model.  We observed increased disc height and NP hydration, 
two markers of disc degeneration, in all treated groups.  The highest improvement was 
exhibited in rats treated with the riboflavin-crosslinked collagen gels. 
The third, and final aim discussed in this dissertation employed the same 
athymic rat tail puncture model to understand the effect of cell-seeded collagen gels on 
AF repair. Primary ovine AF cells were isolated and added to the crosslinked collagen 
gel formulations before injection into an in vivo AF defect.  We observed greater disc 
height and NP hydration in animals treated with the cell-seeded collagen gel.  
Furthermore, cell-seeded gels exhibited integration with surrounding native AF tissue.  
These experiments establish that riboflavin-crosslinked collagen hydrogels are an 
excellent foundation for an annular repair therapy, and can be used to deliver cells in 
order to enhance repair.
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CHAPTER 1 
Introduction: 
1.1 The Annulus Fibrosus 
Vertebrate animals are allowed central motion and flexibility through the 
spinal column, which consists of an alternating series of vertebral bones and 
cartilaginous intervertebral discs (IVDs).  Each IVD is comprised of two distinct main 
regions, an inner nucleus pulposus (NP) and outer annulus fibrosus (AF).  The NP is 
gelatinous, glycosaminoglycan (GAG) rich, and as such very hydrated when normal 
and healthy.  It comprises the core of the IVD, encased between the adjacent vertebral 
bodies and inside of the AF1,2. 
Unlike the NP, the AF has a more rigid fibrous structure comprised of 
concentric lamellae.  Each lamella contains type I collagen fibers angularly aligned at 
30-45 degrees from the transverse anatomical plane3.  In the outermost lamellae these 
fibers, called Sharpey’s fibers, run into the adjacent vertebral bodies creating anchors 
within the bone1. Fibers in the inner AF run parallel to the vertebral endplates, creating 
an envelope around the gelatinous NP.  When the IVD is healthy, the NP is 
pressurized between the vertebral bodies and within the annulus, creating tensile 
forces transferred through the annulus via the collagen network.  This interplay 
between the NP and AF makes the IVD a strong but flexible structure, able to 
facilitate motion, such as bending and twisting, as well as the transfer of force through 
the body4–7. 
The IVD exhibits gradual cellular changes from the outer AF to the center of 
the NP3.  The outermost lamella is the most fibrous, with cells that have large 
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processes and interconnected networks like fibroblasts.  Cells in the inter-lamellar 
septae are flat and also have large processes.  Towards the inner AF, the length of the 
cellular processes decreases, with lower interconnectivity between cells.  The nucleus 
contains rounded cells, reminiscent of articular chondrocytes, embedded in a network 
of glycosaminoglycans and type II collagen8. 
1.2 Annulus Damage and Disc Disease 
IVD damage spans a range from 
relatively benign focal lesions in the outer 
AF to full blown degenerative disc disease 
(DDD).  Along this spectrum, is the case of 
a bulging, or herniated disc.  This condition 
occurs when the AF is weakened by age or 
trauma, and pressure in the NP causes the disc to bulge at the damaged site into the 
surrounding disc space9.  Complete loss of AF integrity leads to the displacement of 
NP tissue through a full-thickness AF defect (Figure 1.1)	, putting pressure on the 
surrounding nerves and causing pain.  The architecture of the posterolateral AF makes 
it especially prone to herniation since studies have shown that this region of the IVD 
often possesses more irregularities, creating stress concentrations in transition zones 
that often coincide with the location of disc hernations10–12.  Disc damage at these 
transition zones directly contribute to back pain since the spinal cord and nerve roots 
are located directly adjacent to the posterolateral annulus.  Furthermore, NP tissue has 
been shown to be an irritant to surrounding nerve tissue6,13, often resulting in 
Figure 1.1: Photo of an intra-operation 
AF defect.  Photo courtesy of Dr. 
Roger Härtl 
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inflammation to the associated nerve roots.  If left untreated, the injury will progress to 
full degeneration. 
DDD is a complicated condition, with many causes and manifestations.  
Generally, the afflicted disc exhibits a loss of height, damage to the endplates, 
osteophyte formation close to the endplates as well as changes in both the NP and the 
AF2,11,14.  Major changes in the NP include loss of hydration and GAG content8, with 
normal tissue being replaced with disorganized fibrous tissue.  As the disease 
progresses, the AF begins to undergo phenotypic changes such as the fusing of 
lamellae and eventual ingrowth of nerves and vascular fibrous tissue8,15,16. 
While the physical changes in damaged IVDs play a major role in loss of 
function and diagnosis, researchers have also observed biological and chemical 
changes in animal models of disc degeneration that coincide with the physical 
transformations13,14.  With knowledge of both the physical and biochemical 
manifestations of IVD damage and degeneration, a slew of treatment options have 
become available, ranging from conservative all the way to surgical.  Spine and 
intervertebral disc research efforts have also intensified to continue foster 
understanding of degeneration and new treatment directions. 
1.3 Current Treatment Options 
Much like IVD disease conditions, treatment options cover a range depending 
on type and severity of the damage.  Very severe cases consist of a degenerated disc 
that is no longer able to facilitate motion without pain, and has begun to fuse between 
the adjacent vertebral bones.  In this case, medical personnel would often choose to 
remove the remaining disc and accelerate fusion already occurring within the disc 
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space17,18.  While this creates a stable motion segment, there is often a dramatic loss of 
motion for the patient, even more so if the fusion is done in the cervical or thoracic 
region of the spine.  If the diseased disc space shows little signs of osteophyte 
formation (fusion), or if the patient is young, total disc replacement becomes a more 
appealing option18. 
The majority of total disc replacements are low profile ball-socket joints made 
of synthetic materials.  While they allow for a wider range of motion than a fusion, the 
use of synthetic materials do not allow for biological healing at the disc space19. 
Tissue engineered IVD replacements are currently being developed that look to 
provide the mechanical support necessary to the disc space while allowing for cell 
infiltration and regeneration of the IVD19–24.  This research shows great promise, 
however due to drawbacks in mechanical performance, biomaterial choice and 
regenerative potential, it is favorable to treat disc damage earlier in the degenerative 
spectrum in order to preserve as much native tissue and function as possible. 
The focus on specific NP and AF repair methods has increased recently in 
attempts to treat early degenerative damage.  These repair methods range from solely 
mechanical structures to biological therapeutics meant to induce regeneration of the 
damaged tissue17,25–30.  Nucleus replacements are being developed that have been 
shown to return mechanical function to a damaged IVD once the native NP is 
removed.  Replacements developed with biological materials such as collagen sponges 
have been implanted to return mechanical function while providing a scaffold material 
for tissue ingrowth24.  While results from these studies have been promising, their 
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efficacy is limited due to the lack of integrity in the AF31.  As such, AF regeneration 
and repair strategies have become more prevalent (Table 1.1). 
A slew of surgical treatment options for AF are available for current use in the 
OR, with many more working through the research and development pipeline.  Suture 
methods for small AF defects have been tested on cadaver models as well as in the 
clinic with encouraging results 32–34.  This method is limited by the defect size that can 
be addressed as well the introduction of additional defects to the AF with the sutures.  
Barbed plugs have also been developed that act as a physical barrier to NP 
displacement, however these plastic plugs have been shown to displace or wear and 
break in the disc space causing further damage35.  An internationally available 
technology, called the Barricaid, is anchored into the adjacent vertebral bone and is a 
physical barrier to additional NP hernation36,37.  While promising, these too have been 
displaced or damaged in the disc space.  Furthermore, the anchoring of the implant 
imparts necessary damage the adjacent bone/endplate.  These AF repair technologies 
all provide some mechanical support, but suffer physical failure and do not allow for 
biological healing at the defect. 
1.4 Tissue Engineering For Annulus Repair 
The natural characteristics of the annulus, such as the multi-lamellar structure, 
pose various challenges to research groups in development of AF-mimics and possible 
repair methods.  Many of these characteristics have been recapitulated as part of tissue 
engineered total disc replacements (TE-IVDs).  Nerurkar et al was able to recreate the 
lamellar and angular alignment of the natural AF in electrospun sheets38.  Nesti also 
employed electrospinning to recreate the AF using PLLA sheets19.  Bowles et al 
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recreated the natural circumferential alignment of the AF using primary ovine AF cells 
suspended in a collagen gel allowed to contract around an inner mandrel21,39.  A 
handful of other TE-IVDs exist that attempt to recreate the characteristics of the 
natural AF, with varying degrees of success40–45.  These technologies show potential 
for total disc replacement and possibly large AF region repair, however they would be 
difficult to implement in focal defect repair through modern surgical methods.  As 
such, tissue engineered AF repair methods are developing to address these difficulties. 
When considering AF repair methods, Bron et al. published a set of criteria 
that an effective treatment should satisfy to encourage both mechanical and biological 
healing9.  Since the disc provides both mechanical function in support of stability and 
movement, and biological function as a living tissue, a successful repair method 
should satisfy these criteria9: 
1. Restore mechanical function 
2. Fill gap in the AF 
3. Affix to surrounding tissue 
4. Allow cells to survive, thrive 
5. Do no further damage or cause irritation 
The mechanical repair methods referenced in Section 1.3 have shown limited success, 
with many of the limitations linked to criteria 4 and 5 listed above.  Tissue engineered 
AF structures, while aiming to recreate components of the native AF for replacement, 
often fall short in application to repair when preservation of much of the native AF is 
desirable. 
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Injectable AF repair methods are currently being developed that would allow 
for healing at the defect site while providing short-term mechanical support to prevent 
NP hernation.  Some of these employ currently used surgical glues34,46,47, while others 
have been developed specifically for AF repair46,48–51.  Schek et al have developed at 
genipin-crosslinked fibrin glue that has been shown to meet the mechanical 
performance of native AF tissue, while allowing for high cell viability48.  Further 
studies will help assess the ability of the glue to maintain its place in an actual annular 
defect.  Chik et al. have developed a pre-formed annulus plug made of collagen made 
to keep NP therapeutics from leaking out of the AF once delivered52.  They have 
shown limited success in a rabbit model, with some evidence of osteophyte formation 
even with the treatment.  These studies, although limited, underscore the need to repair 
the annulus to encourage healing.  Furthermore, they support the efficacy of an 
injectable method of AF repair in the treatment of early disc damage.  In both of these 
cases, a “natural” biomaterial was used in order to encourage biological healing the 
defect site.  Fibrin and collagen are found in the body, however fibrin is most closely 
associated with clotting. 
1.5 Collagen: The Biomaterial 
 Collagen is one of the most abundant proteins in the human body, providing 
much of the structural integrity to organs and other structures.  Multiple types of 
collagen have been characterized, but the fibrous type I is known for its contribution to 
tensile load bearing tissues such as the AF.  Each type I collagen backbone is 
comprised of a repeating Glycine-X-Y primary structure in which proline and 
hydroxyproline are the most common side chains in the “X” or “Y” position53,54.  
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These backbones are arranged in a triple helix with “unwound” ends to form the most 
fundamental building block of the collagen fiber, procollagen.  Once procollagen is 
secreted into the extra cellular space, the unwound ends are enzymatically cleaved 
resulting in tropocollagen.  These tropocollagen molecules then assemble into fibrils, 
and then eventually large fibers, such as those seen in the AF53,55–57. 
 The molecular structure of collagen is highly conserved between species, 
making it an excellent candidate for biomedical applications.  Collagen can be sourced 
from a variety of places such as animal skin56, plant material58, and rat tendon59.  Once 
harvested, the collagen can be broken down, purified and reconstituted in many 
forms56. Perhaps the most widespread use of collagen, other than in food, is the 
application of collagen hydrogels in medicine and scientific research. 
 Collagen gels are most often made by harvesting large fibers from one of the 
previously sources, and solubilizing them in an acidic solution.  The low pH disrupts 
the molecular interactions that keep the collagen as fibrils, while preserving the basic 
triple helical structure 59–61.  In preparation for use, the pH of the solution can be 
restored to neutral, allowing the collagen fibrils to polymerize and create a hydrogel.  
These gels have marked advantages for use in research applications such as high 
availability, biocompatibility, and relative ease of use62.  
 While collagen gels have seen tenured use in biomedical research, their 
application is often limited in load-bearing settings.  They are most often employed at 
low densities (<5 mg/ml), which have been known to exhibit weak bulk mechanical 
properties63.  Furthermore, with the common reconstitution methods mentioned above, 
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the large fibrous formation and alignment is lost leading to reduced tensile 
performance compared to natural type 1 collagen tissues64,65.  
The use of crosslinking in collagen hydrogels has been shown to help enhance 
their mechanical performance66–68.  Crosslinking can be achieved using chemical, 
photochemical and thermal means.  The most common crosslinking agents, especially 
for collagen, include aldehydes, enzymes, carbodiimides and sugars69–73.  The 
aldehydes are employed as tissue preservatives because of their ability to create 
relatively irreversible links within tissues, thus “freezing” them in their current state.  
While wildly effective, these aldehydes are toxic and are not normally used for 
biomedical purposes.  Enzymatic and carbodiimide crosslinkers are studied for their 
role in development of tendon and ligaments67,72,74, but have seen limited use is 
biomedical applications.  Sugars have been shown to crosslink over time when in the 
presence of collagen through the Maillard Reaction75,76.  This process, called 
glycation, is most associated with aging and in diabetic populations due to the 
increased presence on glucose in the blood stream77–79.  However, glucose is not the 
only sugar capable of glycation.  Ribose and riboflavin have been used as crosslinkers 
of collagen that also act through glycation66,70,80–82. 
1.6 Riboflavin Crosslinking of Collagen 
Riboflavin is a relatively common molecule with a host of applications ranging 
from nutrition to clinical application.  Its structure consists of a five-carbon ribose 
backbone with a three-ring flavin bonded to the end of the chain.  While its most 
traditional usage is as vitamin B2 in supplements and food additives, it is employed in 
research as a fluorescent dye and crosslinker. 
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As a type-I photocrosslinker, riboflavin interacts directly with the collagen to 
create crosslinks 59,81.  It is currently used clinically in the treatment of the ocular 
condition keratoconus 68, in which structural stability in the cornea is lost causing it 
bow out.  A riboflavin solution is introduced to abrasions made on the cornea and the 
eye is exposed to UVA light in order to initiate crosslinking of the existing corneal 
collagen fibers68,83,84.  This strengthens the cornea, preventing further deformation and 
preserving eyesight. 
In scientific research, riboflavin has been studied as a method for preventing 
fibrous collagen construct contraction66.  When seeded with cells, type I collagen gels 
will contract over time, which is unfavorable in applications where size and shape 
fidelity are needed.  Post-glycation with riboflavin has been shown to prevent the 
contraction of low density collagen gel constructs, while preserving high cell 
viability66.  The use of UVA light in the initiation of crosslinking is not required, as 
blue wavelength light can initiate the crosslinking process as well85, further enhancing 
the biocompatibility of riboflavin crosslinking. 
1.7 Objective Statement 
With this work, we endeavor to establish collagen hydrogels as an injectable 
repair for the damaged annulus fibrosus.  Collagen is a versatile biomaterial that has 
been shown to be applicable to a wide variety or biomedical applications, including 
the intervertebral disc.  Once crosslinked with riboflavin, the applicability of the gel as 
an injectable repair method increases due to the enhanced mechanical performance 
while maintaining the biological compatibility needed for long-term healing. 
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1.8 Specific Aims 
This dissertation investigates the use of collagen hydrogels for injectable repair 
of the annulus fibrosus through three aims: 
1) Establish the efficacy of collagen hydrogels in an in vitro model of AF repair 
through screening multiple gel formulations and evaluating the mechanical 
effects on an entire IVD. 
2) Investigate the ability of crosslinked collagen gels to biologically repair the AF 
and observe the effects of repair on disc degeneration. 
3) Evaluate the effect cell-seeding on the integration of crosslinked collagen gels 
with the remaining native AF
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CHAPTER 2 
Injectable, high-density collagen gels for annulus fibrosus repair: An in vitro rat 
tail model. 
This chapter has been published: 
Borde, B., Grunert, P., Härtl, R., & Bonassar, L. J. (2015). Injectable, high-density collagen 
gels for annulus fibrosus repair: An in vitro rat tail model. Journal of Biomedical Materials 
Research - Part A, 2571–2581. http://doi.org/10.1002/jbm.a.35388 
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2.1 Abstract 
A herniated intervertebral disc often causes back pain when disc tissue is 
displaced through a damaged annulus fibrosus.  Currently the only methods available 
for annulus fibrosus repair involve mechanical closure of defect, which does little to 
address biological healing in the damaged tissue.  Collagen hydrogels are injectable 
and have been used to repair annulus defects in vivo.  In this study, high-density 
collagen hydrogels at 5, 10 and 15 mg/ml were used to repair defects made to intact rat 
caudal intervertebral discs in vitro.  A group of gels at 15 mg/ml were also crosslinked 
with riboflavin at 0.03 mM, 0.07 mM or 0.10 mM .  These crosslinked, high-density 
collagen gels maintained presence in the defect under loading and contributed 
positively to the mechanical response of damaged discs.  Discs exhibited increases to 
95% of undamaged effective equilibrium and instantaneous moduli as well as up to 
four fold decreases in effective hydraulic permeability from the damaged discs. These 
data suggest that high density collagen gels may be effective at restoring mechanical 
function of injured discs as well as potential vehicles for delivery of biological agents 
such as cells or growth factors that may aid in the repair of the annulus fibrosus. 
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2.2 Introduction 
A bulging or herniated intervertebral disc (IVD) can cause back pain, leg pain 
and neurological deficits when the nucleus pulposus (NP) is displaced through a 
damaged annulus fibrosus (AF).  AF damage occurs in a variety ways including 
natural weakening over time, trauma, or as an unintentional result of medical 
treatment (e.g. discography, discectomy).  In the United States, an estimated $90 
billion per year is spent on assessment and treatment of lower back pain alone 86.  This 
damage also affects the motion segment mechanically, with loss of disc stiffness 12,87,88 
and biologically, in subsequent degenerative effects 87,89–91.  
In most cases, partial discectomies alleviate the pain of a bulging or herniated 
disc; however the resulting annular defect is often left untreated.  This increases the 
likeliness of recurrent disc herniations through the open defect.  Clinical studies have 
shown that the rate of recurrent herniation after partial discectomy lies between 5%-
20% with many of the patients requiring additional procedures.  Furthermore, the rate 
of reherniation has been shown to correlate with the size of the original surgical defect 
9,92,93.  In order to improve recovery after treatment, it is highly desirable to address the 
remaining AF defect after discectomy. 
Annulus repair strategies have been devised to address many different defects 
in damaged AF tissue 31,32,35,37,48,94,95.  These therapies aim to mechanically close 
lesions in the AF to prevent prolapse and perhaps slow or inhibit degeneration.  The 
types of annulus closure treatments that are in development range from purely 
mechanical methods to tissue engineered strategies, all with varying degrees of 
success.  Many mechanical strategies are already commercially available (i.e. suture, 
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barrier, plug).  These mechanical treatments block the AF defect while inhibiting short 
term reherniation.  Studies have shown that disc compressive mechanical properties 
are affected when the annulus fibrosus is subject to full thickness defects, leading to 
diminished time dependent mechanical behavior and eventual degeneration16,96,97.    
While these solutions address the load bearing requirements of the IVD, they do not 
encourage the long-term regeneration of tissue in the damaged area, which is 
intrinsically difficult to achieve due to the limited self-healing potential of the AF 98.  
Tissue engineered strategies are being developed with the goal of achieving 
biological healing, along with satisfying the requirements for mechanical support.  
Various scaffolds such as fibrin and silk have been used to develop laminates or 
adhesives to address the damaged AF.  Furthermore, a host of studies have examined 
the effectiveness of different cell/scaffold combinations in creating AF-mimicking 
structures 38,44, while others have created tissue engineered total disc replacements 
with a construct that mimics the native AF 5,19–21,99.  These approaches are promising 
but their effectiveness in repairing AF defects in situ has not been reported.  A major 
obstacle for many tissue engineering approaches is delivery of the material or device 
to an irregularly shaped defect.  For clinical use, an injectable formulation is desirable 
due to the potential delivery by minimally invasive approaches.   
Collagen hydrogels have been used for a variety of tissue engineering 
applications, enabling delivery of many cell types including chondrocytes and IVD 
cells 66,100.  Collagen is injectable and highly biocompatible in the disc space as both 
an NP replacement material and AF repair material 101,102. Typically, collagen gels are 
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weak and exhibit low stiffness at densities less than 5mg/ml.  However, gel stiffness 
can be tuned by controlling concentration or crosslinking 69,70,82,103–105. 
A variety of crosslinking agents have been used with collagen, including 
formaldehyde, and glutaraldehyde.  Although their effectiveness has been proven, 
these aldehydes are also cytotoxic, thus limiting their application in biological 
systems69,103.  To address these limitations, groups have used sugars and flavins to 
induce crosslinking in collagen-based structures66,70.  Riboflavin is particularly 
attractive because it is used clinically to strengthen the collagen structure of the cornea 
in the treatment of keratoconus68,106.  Further, riboflavin is photo activated and as such 
crosslinking is tunable by exposure to UVA-wavelength light.  Riboflavin crosslinking 
of collagen gel constructs was shown to increase their mechanical stiffness while 
maintaining high cell viability66. These factors make riboflavin crosslinking a viable 
tool in the use of collagen hydrogels for tissue engineering. 
We have successfully used high density, riboflavin-crosslinked collagen gels in 
an in vivo rat tail AF repair model.  Crosslinked gels slowed or prevented the onset 
and progression of degeneration in rat caudal IVDs as evidenced by higher disc 
heights and NP hydration than untreated discs for up to 5 weeks after treatment102.  
Furthermore, discs treated with crosslinked collagen gels maintained healthy disc 
phenotype as seen in histological sections.  Although these results were encouraging, 
the mechanical contribution of injectable repair with these gels is unknown.  This 
study investigated the use of injectable, crosslinked high-density collagen gels to fill 
and mechanically repair focal defects in the annulus fibrosus of a rat caudal 
intervertebral disc.  We report the effect of different defect sizes on effective disc 
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mechanical properties, as well as the effects of increasing gel collagen density and 
riboflavin concentration on effective disc stiffness and hydraulic permeability. 
2.3 Materials and Methods 
Mechanical testing was performed on intact, cadaveric rat caudal motion 
segments to assess the extent to which injectable collagen gels restored performance to 
damaged intervertebral discs.  In parallel studies, the effect of two different sized 
defects were examined, with each motion segment tested prior to damage, after the 
introduction of a defect to the AF, and after this defect was filled with a high density 
collagen gel.  In separate studies the effect of crosslinking was assessed using a range 
of concentrations of the photocrosslinking agent riboflavin. 
Collagen gel preparation 
Collagen fibers were harvested from rat tail tendons as described previously 
39,104,107.  The resulting collagen mass was then weighed and digested in a 0.1% acetic 
acid at a concentration of 150 ml/g tendon for at least 48 hours.  Digested collagen 
was then centrifuged at 9000 RPM for 90 minutes at 4°C and the supernatant collected 
and frozen at -80°C.  After lyophilization for 48 hours, the dehydrated collagen was 
weighed and reconstituted in 0.1% acetic acid at the stock concentrations of 6, 12, and 
20 mg/ml.  Each collagen stock solution was stored at 4°C until use.  
For high-density samples, final collagen gel solutions at 5, 10, and 15 mg/ml 
were made by mixing the acidic stock solutions with basic working solutions 
composed of 10x Dulbecco’s Phosphate Buffered Saline (DPBS), 1N sodium 
hydroxide (NaOH) and 1x DPBS. Each working solution was dyed with trypan blue at 
a ratio of 10:1, respectively, to track the fate of the injected gel.  Crosslinked collagen 
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gels were mixed at the highest density (15 mg/ml), with varying amounts of riboflavin.  
Each gel was prepared in the method above, however riboflavin was added to the 1X 
DPBS at concentrations of 0.25, 0.50, or 0.75 mM , resulting in gel concentrations of 
0.03, 0.07, and 0.10 mM respectively.  Upon delivery to the defect site, crosslinked 
gels were exposed to 468 nm blue light (~1400 mW/cm2) for 40 seconds to initiate 
crosslinking. 
Dissection and segment handling 
Frozen tails from 34 7-8 week old Sprague-Dawley rats were thawed in room 
temperature DPBS.  The skin was removed and the tissue was dissected from the most 
proximal three vertebrae.  The most proximal complete motion segment (bone-disc-
bone) was cut from the rest of the tail at the adjacent intervertebral disc.  Remaining 
tail material was discarded and the dissected motion segments were kept in room 
temperature DPBS.  After the first phase of mechanical testing, a defect was created at 
the midline of the intervertebral disc by either rotating a beveled 21-gauge needle 
(small), or by removing a ~1 mm2 window of the AF using a #11 scalpel blade (large) 
(Figure 2.1).  Each defect was limited to only the AF by using a depth stopper 
(small)108 or using care to only remove the AF with the scalpel (large).  The damaged 
motion segment was tested mechanically again before filling the defect with the 
desired final collagen gel solution.  About 100µL of the collagen gel was delivered to 
each defect using a 27-gauge precision tip needle (Nordson EFD, Robbinsville, NJ).  
Allowing 30 minutes for collagen gel polymerization after delivery, the motion 
segment was mechanically tested again.  Upon completion of testing, the segments 
were either stored at -20°C for gross examination, or processed for histology.  
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Mechanical testing 
Dissected motion segments were loaded into an Enduratec ELF 3200 test 
frame (Bose, Eden Prairie, MN) using custom grips (McMaster-Carr, Aurora, OH)21.  
All manipulation of the motion segment was performed while mounted on the load 
frame so as to preserve the original undamaged height of the motion segment.  Each 
motion segment was allowed to relax for 10 minutes to ensure all initial transient 
effects were gone before testing began.  Stress-relaxation testing was performed on 
each motion segment in steps of 5% compressive strain to a total displacement of 20% 
initial disc height.  Testing in this manner allowed us to observe compressive stiffness 
as well as the hydraulic permeability from relaxation.  This loading scheme was 
performed on the undamaged motion segment and repeated for both damaged and 
treated phases.  
Data Analysis and Statistics 
Load data were recorded directly during mechanical testing at 1 Hz for 50 
minutes.  All data analysis was performed using Excel or MATLAB software.   Load 
curves were generated for each test in order to qualitatively compare disc behavior 
before and after treatment with the collagen gels.  Using a custom MATLAB script, a 
poroelastic model (Figure 2.2, Equ. 1) was fit to the raw load data to determine the 
effective equilibrium modulus (A+B), effective instantaneous modulus (B) and time 
constant of relaxation (τ) with time (t). Effective hydraulic permeability (k) was 
calculated using the equilibrium modulus (E), disc radius (r), and time constant from 
poroelastic model fit (Figure 2.2, Equ. 2)21,104,109.  One-way ANOVA with repeated 
measures including Tukey’s HSD test for post hoc analysis was conducted to examine 
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the general effect of injectable collagen gel treatment on all samples.  Analysis of the 
separate effects of collagen gel density or crosslink concentration was carried out 
using separate one-way ANOVA with Tukey’s HSD test for post hoc pairwise 
analysis.  All statistical analyses were conducted using JMP. 
Histology 
Whole IVDs were dissected from the frozen motion segments and fixed in 
10% formalin for at least 48 hours before transfer to 70% ethanol.  Fixed discs were 
embedded in paraffin wax and sectioned parallel to the transverse plane and affixed to 
glass slides.  Histological slides were stained with Safranin-O with a Fast Green 
counterstain for proteoglycan content and general tissue architecture.  Stained slides 
were viewed under bright-field microscopy for NP content and general tissue 
organization. 
2.4 Results 
The ability of high density, crosslinked collagen gels to repair defects in the 
AF of rat caudal IVDs was assessed both visually and quantitatively though effective 
disc mechanical properties.  Photographs of transverse cross-sections of discs treated 
with 10 and 15 mg/ml gels in smaller defects (Figure 2.3a and 2.3b) and 15 mg/ml gel 
in the larger defect (Figure 2.3c) demonstrated the presence of dyed collagen gels in 
all cases, after the completion of the loading studies.  In all cases collagen was present 
in the AF defect, while in the larger defect, some gel was also observed in the NP 
space.  Histological analysis showed a clear defect in the AF created with both the 21-
gauge needle and scalpel blade, severing all lamella and exposing the NP (Figure 2.4).   
Figure 4 shows a small defect repaired with a crosslinked collagen gel, with a gel 
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patch adhered to the outer AF.  Figure 2.4 also shows a large defect treated with a 
crosslinked collagen, however there is no evidence of the collagen gel after testing.  
These data indicate that injected high density collagen gels remained in place in AF 
defects either in whole or in part after IVDs had been compressed by up to 20%.  
Based on temporal traces of the load, both defects had a profound effect on the 
compressive behavior of the motion segment.  In particular, the instantaneous, peak 
stresses achieved directly after steps in compression were significantly diminished by 
the injury and were partially restored immediately after the injection of the collagen 
gel. Stress relaxation after steps in strain appeared to occur much more rapidly in 
damaged motion segments compared to either uninjured motion segments or those in 
which defects had been filled with collagen gels (Figure 2.5).   
Using the temporal load data, the effective equilibrium and instantaneous moduli and 
effective hydraulic permeability were calculated for both defect types and for all 
collagen gel densities.  The average effective equilibrium and instantaneous moduli of 
uninjured intervertebral discs were 170 ± 54 kPa and 272 ± 133 kPa, respectively, 
while the average effective hydraulic permeability was 2.07x10-14 ± 1.27x10-14 
m2/Pas. These values are similar to those reported previously for rat caudal 
intervertebral discs20,21,110.      
To specifically assess the effect of injury and treatment on the mechanical 
performance of the intervertebral discs, the mechanical properties after injury and 
treatment for each sample were normalized by the value of the uninjured disc. As 
such, all data displayed are unitless, with 1 being the value of the uninjured sample.  
The efficacy of each collagen gel formulation at restoring the effective equilibrium 
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and instantaneous moduli and effective hydraulic permeability were assessed 
separately, as well as pooled to assess the general effect of treatment.  
Larger defects had profound effects on mechanical properties, resulting in 60% 
(p<0.001) decreases in effective equilibrium and instantaneous moduli, and a 400% 
(p<0.05) increase in hydraulic permeability, compared to smaller defects which 
produced 18% and 28% (p<0.05) decreases in moduli and a 114% (p<0.01) increase in 
permeability (Figure 2.4). Treating AF defects with collagen gel formulations 
increased the effective equilibrium modulus of samples with small defects to 85% of 
uninjured values. In contrast, filling large defects with collagen gels had little effect on 
the effective equilibrium modulus.  Delivery of collagen gels nominally increased the 
effective instantaneous modulus by 6-8% of the undamaged values, but this change 
was not statistically different from the damaged case. The largest effect of delivering 
collagen gels to the defect was in restoring the hydraulic permeability of samples with 
small defects.  Delivery of collagen gels decreased the effective hydraulic 
permeability from 215% of the undamaged value to 133% of the undamaged value 
(p<0.05 compared to damaged and p>0.98 compared to damaged). Treatment with 
collagen gels had a similar effect on the effective hydraulic permeability of 
intervertebral discs with large defects, which were 600% of control both before 
treatment and 400% after repair. 
Collagen gel density showed no significant impact on AF repair in small 
defects.  Collagen gels of 5 mg/ml increased effective equilibrium and instantaneous 
moduli slightly over the damaged value.  All three tested gel densities decreased 
effective hydraulic permeability by 50% from damaged values.  In samples with larger 
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defects, both 5 and 10 mg/ml samples did not improve effective equilibrium or 
instantaneous modulus.  However, samples treated with 15mg/ml gels exhibited 
dramatic improvement in effective equilibrium modulus, with an increase to 70% of 
undamaged from the damaged mean of 50%.  Effective instantaneous moduli in these 
samples exhibited a greater increase of 30%, which was statistically significant 
(p<0.05).  All three tested collagen gel densities decreased effective permeability in 
large defect samples. 
In small defects, riboflavin crosslinking of collagen did not statistically 
increase moduli; however the nominal increases in modulus were such that samples 
treated with crosslinked gels were not significantly different than uninjured samples.  
At the highest concentration of riboflavin, effective equilibrium modulus was 95% of 
undamaged.   Crosslinked gels all decreased hydraulic permeability, with 0.10 mM 
group falling to within 5% of the undamaged mean.  In large defect samples, none of 
the experimental groups exhibited increased effective equilibrium or instantaneous 
moduli significantly over damaged values.  Non-crosslinked gels showed the most 
profound increase with effective equilibrium and instantaneous moduli rising to 75% 
and 70% of undamaged values, respectively.  Although all three experimental groups 
decreased hydraulic permeability in large defect samples from 6-fold to 4-fold over 
undamaged, non-crosslinked controls exhibited the most profound decrease with a fall 
to 3-fold over undamaged discs. 
2.5 Discussion 
The goal of this study was to assess the effect of increased collagen density 
and riboflavin crosslinking on repair of AF defects with injectable collagen gels.  This 
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was accomplished through gross visual evaluation and comparison of mechanical 
properties with undamaged discs.  We report several metrics that captured the 
mechanical performance including effective moduli and hydraulic permeability.  It is 
shown here that injectable high density type I collagen gels had a positive effect on the 
mechanical behavior of injured IVDs once delivered to focal defects in the annulus 
fibrosus. Both large and small defects in the AF decreased effective disc moduli and 
increased effective permeability, which collectively represent the diminished ability of 
the disc to bear load. Furthermore, we report that crosslinking with riboflavin had 
limited positive effects, but did not diminish the effectiveness of high-density collagen 
gels for AF repair. 
This study addressed the performance of an annular repair technique directly in 
an ex vivo whole motion segment.  IVD defect models in rat tails are often used to 
study degeneration and to assess possible therapies87,111.  The decision to address two 
defect sizes, created differently, was motivated by the clinical need to address 
different damage types.  Our beveled needle defect simulated standardized diagnostic 
procedures such as a discography, while our larger free-hand defect was meant to 
simulate a surgical intervention (e.g. annulotomy).  Although defect variation adds to 
the variability in “damaged” data sets, it also enhances the rigorousness of our 
approach.  An effective AF repair technique would be expected to comply with the 
irregularities of any AF defect.  Our collagen hydrogel formulations were low 
viscosity upon delivery, allowing it to mold to the form of the defects. 
Repaired IVDs were assessed based on effective equilibrium and instantaneous 
moduli for stiffness as well as effective hydraulic permeability for flow of water out of 
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the disc.  Effective equilibrium modulus and hydraulic permeability values were 
within the range reported previously for rat caudal IVDs 5,110.    Diminished IVD 
performance from the smaller defect was not as profound as that seen with larger 
defect samples; however, in these samples collagen gels were more effective at 
repairing smaller defects.  All three hydrogel densities improved IVD stiffness and 
hydraulic permeability in the small defects.  IVDs with the larger defects also seemed 
to experience some benefit from treatment with collagen hydrogels, with the most 
profound increase in effective stiffness being delivered by 15 mg/ml collagen gels. 
All collagen gel densities improved effective hydraulic permeability in large 
defect samples. The function of the IVD was highly dependent on the ability of the AF 
to keep the NP hydrated and enabling maintenance of large hydrostatic pressure in the 
disc space.  Improvements in IVD stiffness were evident with repair using our 
collagen hydrogel; however the profound decreases in hydraulic permeability 
underscored the ability of high-density collagen gels to contain water within the IVD.  
Tested samples exhibited dramatic increases in permeability when damaged, and 
decreases in permeability of over 2 fold when repaired.  When compared to slight 
changes in both effective equilibrium and instantaneous moduli, it seems that effective 
hydraulic permeability is better suited to evaluate disc mechanical function after AF 
repair in this model.  The hydrostatic pressures and total stresses imposed on repaired 
samples during testing were as high as 83kPa and 150kPa respectively.  These were 
about 20% of those seen in the human lumbar spine while standing 112 and over 80% 
of that seen by the human cervical spine under static loading or bending 18,113.  While 
this result was encouraging, the pressures were only 4% of that seen in lumbar spine 
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while lifting a 45lb weight112, which supports our plan to continue testing these gels in 
a large animal model. 
The improved mechanical responses in repaired IVDs discussed above strongly 
suggest that high-density collagen gels remained in AF defects.  In order to help 
support the mechanical data, gross visual examination was conducted on repaired 
IVDs after mechanical testing.  Gel formulations were dyed with trypan blue to allow 
tracking of the collagen throughout the testing process.  After testing, motion 
segments were frozen and bisected transversely through the repaired disc (Figure 4).  
Blue gels were seen localized to the AF after testing in both the small and large 
defects.  Some evidence of gel in the NP was seen, however it is unclear whether this 
happened during delivery, testing or bisection.  The visual presence of gels after 
mechanical testing confirms that these high-density gel formulations were able to be 
delivered to the defect and maintained presence after compression and processing for 
visual analysis.  Histology shows clear evidence of a patch in small defect samples, 
while there is evidence of material in large defects. 
There studies were motivated in part by previous work demonstrating the 
efficacy of injected collagen gels for repair of AF defects in vivo102.  While promising, 
these previous studies did not address the extent to which these gels restored 
mechanical function immediately after injury.  In both in vivo and in the current study, 
we tested 15 mg/ml collagen gels containing varying amounts of the crosslinker 
riboflavin.  Riboflavin crosslinked collagen gels were best in needle puncture defects 
in either study.  Histology from both studies showed that collagen gel formulations 
work as a patch, with the majority of the injected gel localized to the outer AF.    This 
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patch type repair was successful in keeping the NP intact and in place.  According to 
our study, we would move forward with higher concentrations of riboflavin.  The 
highest concentration (0.1 mM) was observed to have the greatest impact on the 
damaged AF, however the other tested concentrations also had positive effects.  As we 
move forward with larger animal models, we will use larger (0.07+ mM) 
concentrations of riboflavin and maintain a 15 mg/ml collagen gel unless a different 
formulation is needed for increased loading observed in larger animals. 
Our previous in vivo study on AF repair in the rat model supports our 
observation that punctured discs treated with these crosslinked gel formulations 
retained healthy phenotype and NP hydration 102, especially over the long term.   Our 
in vivo samples treated with crosslinked collagen exhibited a brief dip in both dish 
height and NP hydration after surgery, but recovered and maintained higher properties 
by five weeks post-operation102.  Therefore, the crosslinking of the gels may be more 
successful at promoting biological healing as opposed to a purely mechanical repair. 
Until recently, the major focus for annular repair has been mechanical closure 
of the native AF with little attention to biological healing.  Proposed criteria for 
effective AF repair9 include: filling the AF gap; mechanically augmenting injured disc 
function; maintaining or promoting cell survival and/or differentiation; integrating 
with surrounding tissues; and exhibiting biocompatibility.  Our study showed that 
collagen hydrogels can be injected into a gap in the AF and remain in the defect under 
load.  Furthermore, once delivered the gels contributed to the mechanical function of 
the damaged IVDs.  Stiffness of the discs, as assessed by effective modulus values, 
showed increases towards undamaged discs. Our collagen hydrogel formulations have 
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proven to directly satisfy two of the criteria set forth by Bron et al. in an ex vivo AF 
defect model9.  
Remaining factors considered in the literature and criteria above address the 
regenerative nature of AF repair treatments.  An effective repair method must support 
cell survival, cannot be harmful to the surrounding native tissue and must have the 
potential for integration with surrounding tissue. Research groups have showed that 
collagen gels crosslinked with riboflavin are capable of supporting various cell 
types66.  Furthermore, our in vivo studies show that these gel formulations are not only 
harmless to surrounding tissue, but allow for cell migration into the repaired area with 
accompanied native tissue ingrowth102.  Thus, according to the criteria above, our type 
I collagen hydrogel is an ideal candidate for AF repair. 
While the rat caudal motion segment model is widely used in disc degeneration 
and repair studies, there were limitations to the model in this study that cannot be 
overlooked.  The reported work only addressed the short term, mechanical 
contribution of both crosslinked and non-crosslinked high-density collagen gels. 
While it is known that the IVD experiences six degrees of motion in vivo114, 
we only studied axial compression in this model.  Compressive stress-relaxation 
allowed us to observe the dramatic changes in IVD effective permeability with 
puncture.  Our studies have shown that once damaged, the hydraulic permeability 
increases dramatically (up to 6 fold with large defects) over undamaged values.  
Furthermore, other groups have seen changes in time-dependent compressive 
mechanical properties of IVDs with AF damage96,115.  Other testing modalities, such 
as torsion, do not allow us to study the effects on fluid flow out of the disc.   As such, 
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this model represented an important screening tool for assessing AF repair, but must 
be followed with assessment of efficacy in larger animal models, where loading better 
approximates that in humans.   
The method of mechanical testing and analysis used in the current study 
reported effective material properties (i.e. moduli and hydraulic permeability) that 
assume material homogeneity.  Although this did not allow us to address the 
mechanical integrity of the AF or NP directly, it did enable assessment of the effects 
of AF repair on function of the whole IVD as part of a motion segment.  It may be 
beneficial to test the AF directly with the collagen hydrogel repair method once we 
expand the formulation to facilitate repair in larger IVDs, however the effective 
mechanical effects were suitable for establishing the feasibility of a crosslinked, high-
density collagen hydrogel for AF repair. Such an approach could involve directly 
measuring local AF strains116 or analytic finite element models that account for 
differing properties between the AF and NP117. 
Another limitation was that AF defects in the reported work were made while 
maintaining the motion segment at constant height, preventing immediate collapse of 
the IVD upon puncture.  Without immediate collapse, NP tissue was only displaced 
during testing instead of upon puncture, which we experienced during in vivo 
puncture.  NP tissue is known to be lost with puncture or aspiration, which has 
profound effects on mechanical behavior12,87,98.  Although keeping the motion segment 
in displacement control was a concern, histological sections show that we lost a 
considerable amount of NP, especially in large defects (Figure 3).  Furthermore, loss 
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of mechanical stiffness and corresponding increase in hydraulic permeability support 
our observation that we still do lose NP tissue.  
This study demonstrated that crosslinked, high-density collagen gels 
mechanically enhanced the effective properties of damaged IVDs after injection into 
AF defects.  Although the current study used gels alone, multiple studies have used 
type I collagen gels with various additions such as cells, growth factors, and other 
therapeutics to support tissue growth and development 21,62,101. As we move forward, 
we will also look to seed the collagen gels with ovine AF cells, as has been shown 
previously with tissue engineered total disc replacements, which exhibited enhanced 
integration with surrounding native AF tissue21,39.  
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Figure 2.1: Schematic of experimental design showing mounted, undamaged caudal 
motion segment, small and large defects as well as treated drawings. 
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Figure 2.2: Representative temporal data set of an undamaged segment. Inlay shows 
custom MATLAB fit of poroelastic model to single step of stress relaxation data. 
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Figure 2.3: Gross transverse cross-sections of treated IVDs after mechanical testing.  
High density, non-crosslinked collagen gels were dyed with trypan blue to track 
presence in the disc.  Pictures show the presence of gel after loading small defect 
(A&B) as well as large defect (C) samples. 
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Figure 2.4: Safranin-O stained transverse sections of damaged and treated IVDs.  
Histology shows clear defects made with both 21ga. and scalpel blades.  Arrows 
highlight defect sites.  Collagen patch can be seen in treated small defect sample. 
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Figure 2.5: Representative temporal data set of load during a series of stress 
relaxation tests. As shown here, each sample was tested prior to imposition of a defect 
(blue), after damage (red), and after the defect was filled with a collagen gel (green). 
The sample shown here was a small defect filled with a 15 mg/ml collagen gel. 
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Figure 2.6: Normalized effective mechanical properties (pooled) of intervertebral 
discs after injury and after treatment with collagen gel formulations. The values of 
effective equilibrium modulus, effective instantaneous modulus, and effective 
hydraulic permeability were normalized to those of the undamaged disc (dashed line) 
on a sample by sample basis. % indicates that the noted conditions were significantly 
(p<0.05) different from damaged. * indicates that the noted conditions were 
significantly (p<0.05) different from undamaged condition. Error bars represent 
standard deviation.  n=34 
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Figure 2.7: Normalized effective mechanical properties of intervertebral discs after 
injury and after treatment with high density collagen gels. % indicates that the noted 
conditions were significantly (p<0.05) different from damaged. * indicates that noted 
conditions were significantly different from undamaged (p<0.05).  Error bars represent 
standard deviation. n=10±3 
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Figure 2.8: Normalized effective mechanical properties of intervertebral discs after 
injury and after filling with riboflavin-crosslinked collagen gels. * indicates that noted 
conditions were significantly different from undamaged (p<0.05).  Error bars represent 
standard deviation.  n=10±3. 
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CHAPTER 3 
Annular repair using high-density collagen gel; a rat-tail in vivo 
Model. 
This chapter has been published: 
*Grunert, P., *Borde, B. H., Hudson, K. D., Macielak, M. R., Bonassar, L. J., & Härtl, R. 
(2014). Annular repair using high-density collagen gel: a rat-tail in vivo model. Spine, 39(3), 
198–206. http://doi.org/10.1097/BRS.0000000000000103 
*Borde and Grunert are listed in publication as co-first authors on this manuscript 
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3.1 Abstract 
Study design: Animal in vivo study.  
Objective: Test the capability of high-density collagen gel to repair annular defects. 
Summary of background data: Annular defects are related to the occurrence of disc 
reherniations following discectomies and disc degeneration after intradiscal diagnostic 
procedures. Therefore, several biological materials have been developed for annular 
repair and tested in vitro. This is the first study to test a biomaterial in vivo.  
Methods: We punctured the IVD of 42 athymic rats using an 18-gauge needle to create 
an annular defect that leads to extrusion of the nuclear tissue with consecutive 
degenerative changes. Subsequently high-density collagen (HDC) gel was injected to 
seal the defect. Riboflavin (RF) was added to increase the stiffness of the collagen gel 
by inducing cross-link formation. The animals were subdivided into four groups. The 
first group was injected with uncross-linked HDC gel, the second with collagen cross-
linked using 0.25mM RF, the third using 0.50mM RF, and the fourth control group 
was punctured and left untreated. The animals were followed for five weeks with X-
ray measurements to assess the disc heights and MR imaging to evaluate degenerative 
changes of the IVD. We developed an algorithm based on T2-relaxation time 
measurements to assess the size of the nucleus. Tails were collected for histological 
analysis to assess disc degeneration and the cross-sectional area of the NP.  
Results: After five weeks, the 0.50mM RF cross-linked group showed only minimal 
decrease of nuclear tissue when compared to healthy discs, with no obvious signs of 
IVD degeneration. The AF appeared partially repaired by a fibrous cap bridging the 
defect. The 0.25mM RF group showed signs of moderate degeneration with extrusion 
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of nuclear tissue. After five weeks, the uncross-linked group was not significantly 
different from the control group that showed signs of progressive degenerative 
changes and no residual NP tissue in the disc space.     
Conclusion: HDC is capable of repairing annular defects induced by needle puncture. 
The stiffness of HDC appears to influence the repair mechanism. 
3.2 Introduction 
Repair of annular defects could significantly improve treatment of 
degenerative spinal diseases.1  Open defects compromise the ability of the annulus 
fibrosus (AF) to contain nuclear tissue in the disc space, thereby increasing the 
likelihood of reherniation and progressive degeneration after discectomies.2–6  
Furthermore, there has been concern that annular puncture for therapeutic or 
diagnostic procedures accelerates the progression of degenerative disc disease and 
promotes nuclear tissue extrusion.7  Successful treatment of puncture defects could 
inhibit these degenerative changes.   
Annular defects persist because of the very limited intrinsic healing capability 
of the AF, which does not significantly improve upon simple mechanical closure.1,8–11  
As a result, several research groups have investigated using biological materials for 
annular repair.   
Rigid implants have been studied by Vadala et al. using tissue-engineered AF 
constructs in vitro12 and by Ledet EH using small intestinal submucosa in vivo.13 
Implanted submucosa tissue reduced degenerative changes after annulotomy in sheep 
spine.   
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Schek et al. have studied injectable biomaterials with genipin cross-linked 
fibrin hydrogels.  Fibrin integrated with sections of human AF tissue, showing 
promising biomechanical and cell seeding properties in vitro.14  Our group tested 
injectable high-density collagen (HDC) gels and found that HDC can partially restore 
mechanical function to a needle-punctured rattail AF in vitro.15  However, no studies 
reported use of injectable biomaterials to treat annular defects in vivo. 
Annular defects induced by needle puncture lead to predictable patterns of disc 
degeneration in the rat-tail spine.16,17  In such models, degeneration is initiated by 
extrusion of nucleus pulposus (NP) tissue through the puncture defect. Although the 
needle puncture model has been frequently used to test biological materials for IVD 
regeneration,18–21  no study yet has used this model to investigate repair of induced 
defects to prevent disc degeneration. 
The goal of our study was to evaluate the ability of HDC to repair a needle-
puncture AF defect in the rat-tail spine. Specifically, we wanted to test whether 
injected HDC gel can prevent nuclear tissue extrusion and consequent IVD 
degeneration, as determined by histological and radiological outcomes. In addition, we 
assessed whether cross-linking of injected collagen influences the repair process. For 
that purpose, riboflavin (RF), a photoactive initiator of collagen cross-linking, was 
added in different concentrations. In the presented study, the rat-tail model was used to 
screen these various compositions of collagen gels. 
3.3 Methods 
Study groups 
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We used 42 male, 10–12 week-old, inbred, nude, athymic rats for this study. 
Animals were divided into four groups. The first group of 14 was needle-punctured 
and injected with HDC of 15mg/ml concentration. The second group of 16 was 
punctured and injected with RF cross-linked HDC (15mg/ml): nine with 0.25mM RF, 
and six with 0.5mM. A third group of six was punctured and left untreated to serve as 
control. All the animals in these three groups were sacrificed after five weeks. Tails 
were collected and used for histological analysis. A fourth group of six animals was 
sacrificed; tails were collected and subsequently needle punctured and injected with 
HDC. This group was used to study the morphology and distribution of the collagen 
directly after injection. 
All animals were euthanatized with carbon dioxide following standard protocol 
from the American Veterinary Medical Association.  The study was approved by and 
undertaken in accordance with guidelines outlined by the Hospital of Special Surgery 
Institutional Animal Care and Use Committee (IACUC) and New York State. 
Collagen gel preparation 
Collagen was harvested and reconstituted from rat-tail tendon as previously 
described.22,23  Fibers were digested in 0.1% acetic acid, frozen for 48 hours, 
lyophilized and reconstituted at 20mg/ml in 0.1% acetic acid. Immediately before 
delivery, acidic collagen solutions were mixed with working solutions consisting of 
10X Dulbecco’s Phosphate Buffered Saline (DPBS), 1N NaOH and 1X DPBS to 
initiate polymerization of final collagen gels at 15mg/ml. For RF groups, riboflavin 
was added to 1X DPBS at the desired concentration. Gels with RF were exposed to 
blue light with a 480nm wavelength for 40 sec after injection to initiate cross-linking. 
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Open needle puncture and collagen injection 
The target level between the 3rd and 4th vertebra of the tail was localized 
under X-ray control. The animals were anesthetized and placed in the prone position. 
A 2cm longitudinal skin incision was made over the marked level. The AF was then 
exposed, and great care was taken to preserve it without damage. Subsequently the AF 
was punctured using an 18-gauge needle attached to a syringe containing the collagen 
gel. Approximately 0.5 ml of the gel was injected around the defect immediately after 
puncture. When RF was added to the collagen, the gel was cured in situ. The control 
group was punctured and left untreated. In order to standardize the puncture technique 
the needle was always inserted in the same orientation (with the needle bevel up) and 
to the same depth (until the bevel completely penetrated the AF). 
Quantitative MR Imaging 
Quantitative imaging was utilized to assess the size of the NP according to the 
number of MRI voxels that composed it, here labeled NP voxel count. MR imaging 
was obtained on a 7T MRI (Bruker 7T USR Preclinical MRI System) at one, two and 
five weeks post puncture (Fig. 3.1A).  
We used a sagittal multi-slice multi-echo (MSME) pulse sequence 
(TR=2000ms, TE=12ms, NEX=2, number of echoes=12, echo spacing=12ms, slice 
thickness=1mm and matrix size=320 × 320, resolution: 125µm × 125µm × 1mm) to 
create a T2 map based upon fitting semi-log plots of T2 signal intensity versus 
relaxation time for the twelve acquired echoes.  Bruker’s proprietary program 
TopSpin™ was used for the fitting process. A color map was assigned to the resulting 
T2 map (Fig 3.1B). Next, a standard region of interest (ROI) measuring ~1mm2 was 
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drawn within the center of NP of the healthy disc proximal to the punctured IVD. The 
average T2-RT of that ROI was measured, and this value minus two standard 
deviations was used to set a subtraction threshold for all voxels in that slice (Fig. 
3.1B). Voxels with T2 values lower than the threshold were subsequently subtracted 
(Fig. 3.1C). As a result, only voxels with T2 values representing NP tissue remained in 
the disc space and were then counted. At each time point, the mean voxel count of 
punctured discs was compared to the mean voxel count of proximal adjacent healthy 
IVDs. 
Qualitative MRI analysis 
A sagittal TurboRare sequence (TR=2017, ms, TE=60ms, NEX=6, echo train 
length=12, slice thickness=1mm and matrix size=320 × 320, resolution: 125µm × 
125µm × 1mm) was utilized for qualitative assessments. We used a modified 
Pfirrmann scale24 that outlines four grades of degeneration as defined by NP signal 
intensity, homogeneity and loss of disc height. 
Disc height measurements 
Disc heights were obtained in a digital radiographic cabinet. Great care was 
taken to achieve true lateral X-rays of the index segment. The IVD height was 
expressed as a disc height index (DHI), calculated by dividing disc height by adjacent 
vertebral body height based on the modified method of Lu et al.25 The disc height was 
measured preoperatively and postoperatively at one, two and five week time points. 
Histology 
After appropriate fixation, tails were decalcified, cut mid-sagittally and 
transferred to 75% ethanol. Segments were embedded in paraffin, then cut to 5µm 
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thickness and stained with Alcian Blue and Safranin-O. We measured the size of the 
NP by drawing a ROI around the nucleus and subsequently measured the cross-
sectional area of that ROI using the Bioquant image program (Fig. 3.2). The average 
cross-sectional area measurements of punctured discs were compared to those of 
healthy proximal adjacent IVDs. The Han grading system was used to describe the 
degenerative stage of the punctured IVDs. This system is based on AF/NP cellularity, 
morphology and border.17 The grading system ranges from 5, a healthy disc, to 15, a 
terminally degenerated disc. 
Statistics 
The NP voxel count and disc height data were evaluated using nested 
multilevel ANOVA modeling with nesting in punctured and healthy adjacent levels, 
untreated puncture versus collagen injection, and riboflavin concentrations. Analysis 
was done in JMP 9.0 (SAS Institute Inc.). We considered p≤0.05 indicated a 
statistically significant correlation between the variables and measured outcomes. 
3.4 Results 
Qualitative MRI 
Five out of six animals in the 0.5mM riboflavin group showed no obvious 
signs of degenerative changes at the five week MRI (Fig. 3.2). The modified 
Pfirrmann Grade of that group ranged from I to III (avg. 1.3). At the same time point, 
all animals in the 0.25mM riboflavin group displayed decreased NP size, yet the 
nucleus remained homogenous and hyperintense (Fig. 3.2). The Pfirrmann grade 
ranged from II to III (avg. 2.6). The uncrosslinked collagen group showed a more 
heterogeneous, smaller NP with a significantly increased AF/NP ratio (Fig. 3.2). The 
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AF bulged into the nucleus giving it an hourglass shape. All animals had a Pfirrmann 
grade of III. Five out of six specimens in the untreated group showed black IVDs, 
indicating terminal disc degeneration (Fig. 3.2). The Pfirrmann grade ranged from III 
to IV (avg. 3.8). 
 NP voxel count 
The control IVDs had an average NP voxel count ranging from 140 to 153 
voxels at 1, 2 and 5 weeks; the voxel count for the 0.5mM RF group was between 129 
(SD±16.3) and 140 (SD±22.5). The 0.25mM RF group exhibited lower values: 71 
voxels (SD±59.14) at week one and 57 (SD±56.40) at the second and fifth weeks. The 
NP voxel counts of both RF groups remained constant between weeks two and five. 
The uncross-linked collagen group showed 46 (SD±25) voxels at week one 
which continuously dropped to 14 (SD±15.6) at week five. The untreated group 
showed the lowest voxel counts values at each time point, decreasing to 5 (SD±4.17) 
after five weeks (Fig. 3.3A). Overall, HDC gel injection significantly increased voxel 
count values (p<0.0001) as compared to untreated discs. Increasing RF concentration 
(0mM, 0.25mM, 0.5mM) proved to significantly increase NP voxel count values 
(p<0.0001). 
Disc height measurements 
All punctured IVDs dropped in disc height after needle puncture but remained 
constant between weeks two and five (Fig. 3.3B). The 0.5mM group maintained an 
average of 84% (SD±8.77) of its initial disc height, the 0.25mM riboflavin group 77% 
(SD±8.72). The uncross-linked collagen group maintained 67% (SD±16.86) and the 
untreated group 53% (SD±13.82) of disc height. Overall, HDC treatment gel 
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significantly improved the DHI (p<0.0001) of punctured discs. Increasing RF 
concentration (0mM, 0.25mM, 0.5mM) significantly increased the DHI (p = 0.0264). 
 Histology 
The annular defect—The needle puncture defect pierced through all AF lamella 
layers (Fig. 3.4A–B, 3.5A–C) and was still visible after five weeks in all animals. In 
the control and uncross-linked groups, the AF fibers remained separated, and 
infiltrated the surrounding scar tissue (Fig. 3.4D). No granulation tissue, increased 
cellularity or vascularity was visible to indicate an annular repair process. The 0.5mM 
RF group showed formation of a fibrous cap at the outer third of the AF that infiltrated 
annular fibers, bridging both disrupted ends (Fig. 3.5). This fibrous cap was composed 
of fibroblasts embedded in a dense collagen matrix that stained more intensely with 
Safranin-O and Alcian blue than surrounding AF and scar tissue. The 0.25mM RF 
group showed formation of either a similar cap (Fig. 3.4A–B) or a thin fibrous string 
repairing the outer part of the AF (Fig. 3.4C). In both cross-linked groups, the inner 
two thirds of the AF showed no signs of tissue repair. 
Disc degeneration—There were no obvious signs of degeneration in the 0.5mM RF 
group. IVDs showed an average Han degeneration grade of 6.8. IVDs in the 0.25mM 
RF group showed a decline in NP cells with clusters formation, and reached an 
average Han grade of 9.3. All IVDs in the uncross-linked collage group showed signs 
of progressed degenerative changes with only residual NP tissue visible in the disc 
space (Fig. 3.2). The puncture defect branched into the AF, creating multiple fissures. 
NP tissue herniated through the open defect (Fig. 3.4E). Discs a showed a Han grade 
of 12.8. 
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All animals in the untreated group showed severe signs of degeneration; the 
NP was completely replaced with connective tissue. The AF appeared ruptured and 
disorganized (Fig. 3.4F). Several specimens showed significant endplate damage (Fig. 
3.2). The average Han grade was 14.3. 
Histological cross-sectional area—After five weeks, healthy NP proximal to 
punctured IVDs had an average NP cross-sectional area of 1.59mm2. Means of 0.5mM 
RF, 0.25mM RF, and uncross-linked collagen groups were 1.29mm2, 0.78mm2, and 
0.78mm2 respectively. No measurable NP tissue remained in the disc space of 
untreated IVDs. 
Fate of the injected collagen 
Immediately after injection, the collagen distributed into the paravertebral 
space covering the outer part of the annular defect but did not migrate into the defect 
(Fig. 3.6). HDC appeared as homogenous amorphous tissue that stained weakly with 
Alcian Blue or Safranin-O. After five weeks residual collagen still appeared 
homogenous and amorphous and was infiltrated with host fibroblasts to varying 
degrees. Resorptive zones were visible, indicating reorganization of the injected 
material by the host cells (Fig. 3.7). No sign of inflammatory or foreign body reaction 
was visible. 
3.5 Discussion 
Summary of our results 
The first objective of this study was to test the ability of HDC to repair annular 
defects in a needle-punctured rat-tail model. We found that collagen can preserve the 
ability of the AF to retain nuclear tissue in the disc space and thereby prevent 
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degenerative changes to the IVD.  We also observed the potential of collagen gel to 
induce formation of fibrous tissue that partially restores annular integrity. The second 
objective was to evaluate whether adding RF affects the quality of AF repair. We 
found that RF improved retention of NP size and disc height for up to five weeks after 
needle puncture. 
The beneficial effect of RF was dose-dependent. In its absence, collagen gels 
yielded only a nominal increase in NP size and disc height compared to untreated 
IVDs. The 0.5mM RF group retained most of its nuclear tissue according to NP voxel 
counts and histological cross-sectional area measurements. An average disc height of 
84% was maintained. Neither MRI analysis nor histological assessment revealed 
significant degenerative changes. 
There are several potential mechanisms by which cross-linking may have 
positively influenced AF repair. Chemical cross-linking is known to increase the 
stiffness and decrease the hydraulic permeability of collagen gels.26–28 Increased 
stiffness may help form a more robust barrier for sealing the defect. Decreased 
hydraulic permeability limits the loss of highly hydrated NP material through the 
defect.15 In addition, cross-linking may enhance collagen adhesion to the AF tissue as 
has been shown with other biopolymer gels.14 This prevents detachment of the 
implanted material from the annulus and subsequent loss of NP tissue. 
A notable histological finding was the formation of a fibrous cap bridging the 
outer portion of the annular defect in both cross-linked groups. Collagen gel showed 
varying degrees of host fibroblast infiltration with signs of tissue reorganization, 
which could explain the formation of this fibrous tissue. The mechanism of host cell 
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invasion with subsequent tissue remodeling of collagen gels has already been 
described in the literature.29,30 Staskowski et al. injected type I collagen gel in a canine 
model and described that secondary fibroblast invasion led to deposition of new host 
collagen within the gel. According to his study, cellular infiltration progressed more 
rapidly in a cross-linked collagen preparation, which could explain why fibrous cap 
formation occurred only in cross-linked groups of the presented study. Further, cross-
linking is known to delay degradation and increase persistence time of collagen 
scaffolds, which would also support cell migration and remodeling.31,32 
RF cross-linking and injectable biomaterials 
RF is already used clinically to cross-link collagen fibers of the cornea to treat 
keratoconus,33 but has never been applied to repair IVD tissue.  RF serves as a 
photosensitizer to induce production of oxygen radicals, which then induce chemical 
bonds between collagen fibrils, thereby cross-linking them.28 Several different 
substances have been used to cross-link biopolymer gels.14,31,32 Using RF is 
advantageous because it cross-links fibers only after activation by blue light in situ, 
allowing collagen gel to remain liquid prior to injection. Injectable biomaterials may 
prove more technically feasible for use in spinal procedures than rigid biological 
implants, as they do not require anchoring to the AF or vertebral body. Moreover, only 
injectable substances can be applied percutaneously. 
The rat-tail model 
The rat-tail model proved to be suitable for testing various compositions of 
collagen gels.  An 18-gauge needle creates a large defect comprising almost the entire 
posterior wall of the AF in the rat-tail disc. This defect is proportionally much larger 
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than defects induced by annulotomy during discectomies or punctures for 
discographies. High intradiscal pressure combined with the liquid consistency of the 
NP leads to rapid extrusion of nuclear tissue if left untreated. Untreated IVDs 
degenerated more rapidly than described in other studies that used the same model 
with a percutaneous approach.16 We believe this is due to the open approach used in 
our study, in which the paravertebral muscles are dissected off the AF, creating a large 
tissue defect. 
Limitations 
We consider the small size of the specimen to be the main limitation of this 
study. The relatively small IVDs did not allow us to inject collagen gel into deeper 
layers of the AF against the intradiscal pressure. As a result, the potential of collagen 
gel to repair deeper layers of the AF could not be studied. It is unclear if the described 
fibrous cap at the outer part of the annulus could mechanically compensate for defects 
in larger animals or humans, whose IVDs are exposed to much higher mechanical 
forces. In addition, the instantaneous sealing of the defect by the injected collagen 
could be less effective under higher axial loads in humans. One other limitation of this 
model is that the AF is not degenerated at the time of collagen injection. A 
degenerated AF, as often seen in discectomy procedures, might respond differently to 
the collagen gel.  However, the potential of collagen gel to induce tissue repair is very 
promising and should be explored in degenerated discs and larger animals. 
3.6 Conclusions 
High-density type I collagen is able to repair annular defects for up to five 
weeks after induction of a needle-puncture defect in the AF of the rat-tail spine. This 
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capability correlates positively with RF cross-linking. The needle-punctured rat-tail 
has been shown to be a suitable in vivo model for studying biomaterials for annular 
repair. Testing different concentrations of RF in longer-term studies will be an 
important next step. Additionally, future experiments may look to increase the size of 
the animal model or to incorporate cell-loading of the collagen gel. 
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Figure 3.1: Illustrating the method used to determine NP size according to T2-RT.  
(A) T2-weighted MRI of a rat-tail with a needle-punctured disc (white arrow).  (B) 
Matching image with T2- RT measurements displayed as a color map. A ROI was 
drawn within the NP of the proximal healthy adjacent disc. A subtraction threshold 
was set at two standard deviations below the T2-RT mean of the ROI.  (C) All voxels 
below the threshold were subtracted. Subsequently, the remaining voxels in the disc 
space were counted. 
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Figure 3.2. Five-week outcome examples of all punctured groups. The displayed 
specimen from the 0.5mM RF group shows only a slight reduction in NP size when 
compared to healthy discs, according to the NP voxel count and histological cross-
section measurements. The IVD from the  0.25RF group shows a reduced nuclear size. 
The NP appears still homogeneous and hyperintense but has lost its oval shape. The 
decreased disc height, which is also seen on X-Ray, results in a Pfirrmann grade of III. 
The uncross-linked collagen injected IVD shows a greater reduction in NP size. The 
NP is still hyperintense but appears more heterogeneous.  The untreated disc shows 
terminal degenerative changes: a black disc on MRI combined with collapsed disc 
space. The NP tissue has been completely replaced with connective tissue. Endplate 
damage is visible. 
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Figure 3.3:  (A) Nuclear size according to NP voxel count measurements. The 0.5mM 
group showed slightly fewer NP voxels than did healthy discs over 5 weeks. Voxel 
counts of both crosslinked groups remained constant between the 2nd and 5th weeks. 
Animals injected with uncross-linked collagen gel showed a continuous drop in NP 
voxels over 5 weeks. The untreated group showed the lowest voxel count numbers at 
all time points.  (B) Disc height initial disc height; the untreated group dropped to 
55%. Variations in n within groups resulted from MRI scheduling constraints. 
measurements correlated with NP voxel count results. The 0.5mM group retained 88% 
of its initial disc height; the untreated group dropped to 55%. Variations in n within 
groups resulted from MRI scheduling constraints. 
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Figure 3.4: Different histological outcomes of punctured IVDs after five weeks.  (A) 
Safranin O stain, 0.25mM RF group. The disc displays an ovular NP of standard size. 
The needle-puncture defect and fibrous cap are outlined by the box.  (B) Higher 
magnification under polarized light. The needle-puncture defect is clearly visible (red 
arrows). The inner 2/3 of the AF lamellae remain separated; there is no sign of tissue 
repair. The outer 1/3 of the defect is bridged by a fibrous cap (FC). The non-
birefringent FC matrix appears to infiltrate the bright, birefringent AF fibers.  (C) 
Alcian blue stain.  0.25mM RF group. Only a thin fibrous string (black arrows) 
bridges the annular defect (red arrows). (D)  Alcian blue stain. Uncross-linked group 
. No fibrous tissue visible repairing the defect (red arrows). Distal annular fibers 
(DAF) and proximal annular fibers (PAF) remain separated and infiltrate the 
surrounding scar tissue (ST). The black arrow points to sequestered NP material. B 
indicates endplate bone. (E)  Alcian blue stain. Uncross-linked group . NP tissue 
(black arrow) extrudes through the annular defect into the paravertebral space. The AF 
shows multiple fissures (red arrow). (F) Untreated control IVD . Needle-puncture 
defect (red arrow) induced severe degenerative changes. There is no organized AF 
tissue visible; the NP has been replaced with connective tissue. 
 
 
58 
 
 
Figure 3.5: Safranin O stain. Punctured IVD, 0.5mM RF group after 5 weeks. ( A) 
Low magnification. The NP displays standard size and ovular shape. A clear border 
separates the NP from the AF and endplate bone B. The box marks the needle 
puncture defect. ( B) Higher magnification shows the needle puncture defect piercing 
through every layer of the AF. A fibrous cap, marked by the box, bridges the annular 
defect at the outer portion of the AF. The matrix of this fibrous tissue stains more 
intensely with Safranin O than does the surrounding scar tissue (ST).  (C), (D) Higher 
magnification of the fibrous cap, which appears to be infiltrating AF fibers. (E), (F)  
Same specimen as in A–C, viewed under polarized light. The bright birefringent AF 
fibers mesh with the non birefringent tissue of the fibrous cap. 
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Figure. 3.6: Fate of the collagen gel.  (A) Safranin O stain, polarized light 
immediately after collagen gel (CG) injection. HDC distributes in the paravertebral 
space, covering the AF defect. In contrast to the AF, HDC is non birefringent under 
polarized light, indicating a lower tissue organization.  (B) Higher magnification. The 
puncture defect is visible (red arrows). CG appears as an amorphous homogenous 
tissue, which stains slightly positive for Safranin O. It does not migrate into the AF 
defect. 
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Figure. 3.7: Fate of the collagen. Alcian blue stain. Paravertebral space 5 weeks after 
collagen injection. Three islets of amorphous homogenous collagen surrounded by 
scar tissue. Islet  A shows no cell infiltration, islet  B very limited. Islet  C shows a 
high degree of fibroblast infiltration.  The cells appear to reorganize the tissue, as 
indicated by resorbtive zones (black arrows) within the collagen tissue. There is no 
sign of an inflammatory response.
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CHAPTER 4: 
In Vivo Annular Repair using High-Density Collagen Gel Seeded with Annulus 
Fibrosus Cells 
This chapter has been submitted for publication: 
*Moriguchi, Y., *Borde, B., Pennicooke, B., Berlin, C., Kahir, T., Grunert, P., 
Navarro-Ramirez, R., Bonassar, L. J., & Härtl, R. (2016). Annular repair using high-
density collagen gel: a rat-tail in vivo model. Spine, Submitted  
*Borde and Moriguchi are listed in publication as co-first authors on this manuscript 
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4.1 Abstract 
To assess the in vivo efficacy of annulus fibrosus (AF) cells seeded into 
collagen at enhancing the reparative process around annular defects and preventing 
further degenerative changes in a post-puncture rat-tail model.  
Despite alleviating associated neurological symptoms, discectomy of herniated 
intervertebral discs fails to repair the underlying degenerative process. Persistent 
annular defect post discectomy is associated with increased risk of reherniation, 
progressive degeneration, and chronic low back pain. We recently demonstrated that 
riboflavin cross-linked high-density collagen gels (HDC) can facilitate annular repair 
in vivo.  
Forty-two athymic rats, tail disc punctured with an 18-gauge needle, were 
divided into 3 groups: untreated (n=6), injected with crosslinked HDC (n=18), and 
injected with AF cell-laden crosslinked HDC (n=18). Ovine AF cells were mixed with 
HDC gels prior to injection at a concentration of 106 cells/ml. A series of in vivo 
imaging with X-ray and 7T MRI were conducted over 5 weeks to determine disc 
height index, NP size, and hydration. Histological assessments evaluated the viability 
of implanted cells, degree of annular repair, and secondary disc degeneration. 
Both HDC gel groups, AF cell-laden and acellular, had significant retention of 
disc height, NP size, and NP hydration at five weeks when compared to puncture 
controls. Average NP voxel count of cellular gels were higher than those of acellular 
gels at all time points, and statistical significance was demonstrated at 1 and 5 weeks. 
Further histological assessments indicate that while HDC gels influence reparative 
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sealing of the defect, the addition of cells accelerates this process by as early as 2 
weeks.  
AF cell-laden HDC gels have the ability to better repair annular defects than 
acellular gels after needle puncture, thereby suggesting their potential feasibility in a 
cell-based therapy for annular defects.  
4.2 Introduction 
Occurring in 40% of individuals younger than 30 and in more than 90% of 
those older than 50 years of age1, degenerative disc disease (DDD) is a prevalent 
clinical condition that can lead to nerve compression and chronic back pain. Disc 
herniation with radiculopathy is one of the most common DDD-linked clinical 
diagnoses that effects the lumbar spine 2. When pharmacological and 
physiotherapeutic treatments fail to relieve patient symptoms in lumbar disc herniation 
(LDH), a discectomy procedure is often performed, with an estimated 300,000 cases 
per year in the United States3. Although discectomies decompress neural tissue, they 
leave the annular defect or tear untreated. This increases the risk of recurrent disc 
herniation through the open defect, which occurs in 6%-23% of all patients following 
discectomy4-6, and is associated with compromised patient outcomes and increased 
health care costs7,8.  A persistent annular defect is also associated with progressive 
degenerative changes of the intervertebral disc (IVD)9-11, and may be the primary 
cause of chronic low back pain following discectomy12. To date, there is no 
established method for repairing annular defects in order to reduce the re-herniation 
rate and limit the progression of disc degeneration13. 
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A fundamental problem is the low intrinsic healing capability of the annulus 
fibrosus, as demonstrated in animal experiments14,15.  To address this issue, several 
attempts have been made to repair annular defects either mechanically or biologically. 
However, mechanical solutions such as suturing or annuloplasty devices do not 
significantly alter annular healing strength in animal models16 or demonstrate long-
term benefits in clinical trials17. Clinical and experimental biological treatment 
approaches for degenerative disc disease have recently been reviewed [Yu Moriguchi, 
Marjan Alimi, Thamina Khair, George Manolarakis, Connor Berlin, Lawrence J. 
Bonassar, Roger Härtl. Biological Treatment Approaches for Degenerative Disk 
Disease: A Literature Review of In Vivo Animal and Clinical Data. Global Spine J 
DOI: 10.1055/s-0036-1571955]; biological, rigid implants using tissue-engineered AF 
constructs have been tested in vitro18-22. Implants made from small intestinal 
submucosa reduced degenerative changes after annulotomy in the sheep spine23, but in 
order to improve clinical applicability, injectable biomaterials have recently been 
developed. Injectable genipin cross-linked fibrin hydrogels were shown to integrate 
with sections of human AF tissue and showed promising biomechanical and cell-
seeding properties in vitro21. 
A similar solution involves the use of collagen gels, which have been used 
extensively in regenerative therapies due to accumulating evidence supporting their 
biocompatibility and safety24,25. We recently demonstrated that injectable high-density 
collagen gels (HDC) cross-linked in situ by blue light exposure, can effectively seal 
annular defects, facilitate annular repair, prevent further NP herniation and subsequent 
degeneration, and restore disc functionality in an in vivo rat-tail model26,27. In addition, 
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previous studies have shown that fibrochondrocytes, component cells of the AF, 
seeded into collagen, are able to produce a matrix which is similar to the native AF 
and remodel the composite into a more biocompatible and mechanically-stable 
material28,29.  Accordingly, the addition of AF cells can enhance the ability of collagen 
gels to repair annular defects in early to mid-stage disc degeneration.  These cell-laden 
gels can potentially reduce the rate of re-herniation and limit further degeneration, 
yielding a favorable clinical outcome.  
In the present study, we assessed the in vivo efficacy of AF fibrochondrocytes 
seeded into riboflavin crosslinked HDC gels for enhancing the reparative process at 
the site of annular defects, and preventing further degenerative changes, in a post-
puncture rat-tail model.  
4.3 Materials & Methods  
High-density Collagen Gel Preparation. 
Collagen type I was extracted from rat-tail tendons26,27. The tendons were 
dissected and digested in a dilute solution of acetic acid (0.1% 80 mL/g, at 4 ° C for 2 
d). The resulting solution was centrifuged and the collagen concentrated to 20 mg/mL 
by lyophilization and resuspension in acetic acid. 
AF cell isolation and preparation of cellular collagen gels 
Cell preparation was based on previously described techniques28. Lumbar 
spines of skeletally mature sheep were purchased and IVDs were dissected out of the 
segments. Tissue was washed in PBS (Dulbecco’s PBS; Gibco BRL) and then 
separated into AF and NP regions. To isolate AF cells, the AF was dissected into 
small pieces and digested in 200 mL of 0.3% wt/vol collagenase type II at 37 °C for 9 
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hours. Digested tissue was filtered through 100 µm nylon mesh (BD Biosciences) and 
centrifuged at 936 g for 7 min. Cells were counted and seeded at 2,500 cells⁄cm2 in 
culture flasks with Ham’s F-12 media (Corning Mediatech) that contained 10% fetal 
bovine serum, penicillin (Gemini Bio Products), (100 units⁄mL), streptomycin (100 
µg⁄mL), amphotericin B (250 ng⁄mL), and ascorbic acid (25 µg⁄mL). Cells were 
cultured at 37 °C, 5% CO2, and normoxia to confluence with media changes every 3 
days. At confluence, cells were removed from flasks with 0.05% trypsin (Corning 
Mediatech) and counted with a hemocytometer. Cells were then seeded into high 
density collagen gels at a concentration of 106 cells/ml prior to injection. 
Needle puncture-induced degeneration model and collagen injection.  
Forty-two skeletally mature male athymic rats (Hsd: RH-Foxn1rnu) were 
utilized. The animals were 10 to 12 weeks old at time of surgery, with weight of 200-
300 g. All surgical procedures were performed in accordance with the RARC 
guidelines for large animal surgery, including sterilization of surgical supplies, aseptic 
techniques, preoperative care, monitoring and supportive care, surgical procedures, 
and postoperative care. A needle puncture-induced degeneration model was employed 
as previously described26,27 to determine the efficacy of the gel-based treatment in 
comparison with solely punctured control specimens. A total of 42 rats, punctured 
with an 18-gauge needle in the tail disc, were divided into three groups: 1) untreated 
(n=6); 2) injected with crosslinked HDC (n=18); 3) injected with AF cell-laden 
crosslinked HDC (n=18). In brief, a dorsal, 2-cm longitudinal skin incision was made 
and the AF was exposed and punctured. The 18-gage needle penetrated the AF until 
the bevel was completely inserted. In the collagen-injected groups, the IVD was 
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punctured and simultaneously injected with either AF-cell laden or acellular collagen 
gels around the annular defect. In the control group, discs were punctured and left 
untreated. The wound was closed cutaneously with 3-0 polyamide-nylon sutures. 
Postoperative care was provided by Veterinary Services personnel, as per RARC 
guidelines. Sutures was removed 10-14 days postoperatively.  
Qualitative MRI Analysis 
A sagittal TurboRare sequence (TR = 2017 ms, TE = 60 ms, NEX = 6, echo 
train length = 12, slice thickness = 1 mm and matrix size = 320 × 320, and resolution: 
125 µ m × 125 µ m × 1 mm) was utilized for qualitative assessments. We used a 
modified Pfirrmann scale 24 that outlines 4 grades of degeneration as defined by NP 
signal intensity, homogeneity, and loss of disc height30. 
Quantitative Magnetic Resonance Imaging 
All 32 animals underwent 7 Tesla MRI (Bruker 7T UST preclinical MRI 
System, BRUKER AXS Inc., Madison, WI) imaging at 1 week, 28 animals at 2 
weeks, and 24 animals at 5 weeks, postoperatively. For quantitative assessment, the 
voxel count and average T2 relaxation time in NP were measured according to an 
algorism we previously developed31. We used a sagittal multislice multiecho pulse 
sequence (TR = 2000 ms, TE = 12 ms, NEX = 2, number of echoes = 12, echo spacing 
= 12 ms, slice thickness = 1 mm, and matrix size = 320 × 320, resolution: 125 µ m × 
125 µ m × 1 mm) to create a T2 map on the basis of fitting semilog plots of T2 signal 
intensity versus relaxation time for the 12 acquired echoes. Bruker’s proprietary 
program TopSpin was used for this fitting process. A color map was assigned to the 
resulting T2 map. Next, a standard region of interest (ROI) measuring approximately 1 
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mm2 (comprising 90 voxels) was drawn within the center of NP of the healthy disc 
proximal to the experimental segments. The average T2-relaxation time (T2-RT) of 
that ROI was measured, and this value minus 2 standard deviations was used to set a 
subtraction threshold for all voxels in that slice. Voxels with T2 values lower than the 
threshold were subsequently subtracted. As a result, only voxels with T2 values 
representing NP tissue remained in the disc space and were then counted. At each time 
point, the mean voxel count of experimental segments was compared with the mean 
voxel count of proximal adjacent healthy discs. The mean T2-RT of aforementioned 
NP voxels was also calculated and compared with that of the healthy control. 
Disc Height Measurements 
X ray imaging was performed at one, two and five weeks to measure the disc 
height of treated segments. Great care was taken to achieve true lateral radiographs of 
the index segment. The IVD height was expressed as a disc height index, calculated by 
dividing disc height by adjacent vertebral body height on the basis of the modified 
method of Lu et al.32.  
Histology 
Animals were sacrificed at one, two, or five weeks postoperatively. Tail spines 
were collected and processed for further ex vivo histological assessments as 
previously described27. After fixed with 10% neutralized formalin supplemented with 
1 % cetylpyridinium chloride (CPC), specimens were decalcified, cut in the mid-
sagittal plane, and transferred to 75% ethanol. Segments were embedded in paraffin, 
then cut to 5-µm thickness, and stained with Alcian Blue and Safranin-O. 
Statistics 
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All the quantitative values from X-rays and MRIs represent the proportion of 
experimental to adjacent healthy control measurements, and were expressed as mean ± 
SD. For the analyses for continuous outcomes in disc height index, NP size, and NP 
hydration, we employed linear regression models with a generalized estimating 
equation and robust standard errors to estimate differences in mean changes from 
baseline controls (discectomy) across stable and displaced implantation groups for the 
1, 2 and 5-week time points. Statistical analyses were performed with IBM SPSS 
Statistics 22 (SPSS, Chicago, IL, USA). P values <0.05 were considered statistically 
significant.  
4.4 Results 
Qualitative MRI 
On 5-week MR images, all the punctured IVDs, whether treated or not, 
displayed decreased NP size (Figure 4.1). The cellular gel-injected IVD showed 
hyperintense, but slightly heterogeneous NP. The Pfirrmann grade (a semi-quantitative 
measurement of degeneration) of the cellular group ranged from II (moderate) to IV 
(severe), while the punctured and untreated segments had grade IV, indicating 
potentially milder degeneration in the cellular group than the untreated group based.  
The acellular group showed more heterogeneous, smaller NP, with a black fissure in 
the middle as well as a detectable decrease in disc height. The Pfirrmann grade of this 
acellular group ranged from III to IV. The punctured and untreated groups showed 
black IVDs with collapsed disc spaces. 
Disc height Index (DHI) 
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Quantitative analyses based on X rays showed that the cellular (but not the 
acellular) gel had significant retention of disc height at 5 weeks (p=0.020 in cellular vs 
puncture and p=0.102 in acellular vs puncture, Fig 4.2). Although the cellular group 
had a higher mean DHI at all time points compared to the acellular group, this 
difference between the two groups was not statistically significant. Both cellular and 
acellular groups showed arrest of deterioration at 2 weeks in terms of mean DHI (the 
disc height did not decrease), while only the puncture group demonstrated a consistent 
downward trend over time with a statistical significance between 2 and 5 weeks 
(p=0.02). 
NP Voxel Count and T2-Relaxation Time (T2-RT) 
Quantitative MRI analysis demonstrated that the gel-treated groups, whether 
cellular or acellular, had a higher average NP voxel count following needle puncture 
when compared to the puncture group at all time points, with the cellular group having 
the highest mean NP voxel counts. The cellular gels significantly retained NP tissues 
compared to the untreated puncture group at 1 and 5 weeks (p<0.001 and p=0.012, 
respectively), and the acellular group at 5 weeks (p=0.046). Both puncture and 
acellular groups showed a downward trend over time after 2 weeks, while the cellular 
group demonstrated resurgence at 2 weeks in terms of average NP size. However, 
these time-dependent changes failed to demonstrate statistical significance (p>0.05). 
Likewise, both cellular and acellular groups showed significantly higher NP T2 
relaxation time, an indicator of NP physiological hydration, at all time points (p<0.001 
/ <0.001 / <0.001 in acellular vs untreated and p<0.001 / <0.001 / <0.001 in cellular vs 
puncture at 1, 2, and 5 weeks, respectively). In addition, the cellular group 
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significantly maintained NP hydration compared to the acellular group. There was a 
significant time-dependent decrease of NP T2 relaxation time from 1 and 2 to 5 weeks 
in the puncture and acellular group (p=0.004/ 0.021 in puncture and p=0.001/0.002 in 
acellular, between 1 and 5 weeks, and 2 and 5 weeks respectively).  The cellular group 
maintained over 90 % of adjacent native disc T2 relaxation over 5 weeks, displaying a 
much greater retention of hydration than the other groups.  
Likewise, both cellular and acellular groups showed significantly higher NP T2 
relaxation time, an indicator of NP physiological hydration, at all time points (p=0.003 
/ 0.004 / 0.001 in acellular vs untreated and p=0.002 / 0.01 / 0.001 in cellular vs 
puncture at 1, 2, and 5 weeks, respectively). Despite the lack of statistical significance 
in intergroup differences, the cellular group had a higher mean value of NP T2 
relaxation (around 90%) at 5 weeks, although there was a significant overall time-
dependent decrease in NP T2 relaxation time in this cellular group (p=0.005). In 
contrast, the segment treated with acellular gels lost more than 35% of NP hydration at 
5 weeks after needle puncture (p=0.025 in 1 week vs 5 weeks and p= 0.021 in 2 weeks 
vs 5 weeks), suggesting there was a more significant decrease after 2 weeks in this 
group compared to the cellular group. The untreated control group also had a 
downward trend over time, resulting in a significant decrease in T2 relaxation time 
between 1 and 5 weeks (p=0.014). 
Histology 
Histological images stained with Safranin-O demonstrated abundant 
proteoglycan-rich matrices of NP, which is stained in red, in the center of an adjacent 
healthy disc segment (Fig 4.1). The cellular group retained NP tissues in the core but 
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lost more at the peripheral region, which is well corroborated by MRI T2 map images 
(Fig 4.1). Acellular gels, although still retaining some NP tissue, showed an AF bulge 
into the NP, giving the NP an hourglass shape. The NP tissue in the punctured and 
untreated segment has been completely replaced with fibrous tissue at 5 weeks. As a 
proof of terminal disc degeneration, disruption of the endplate was also observed. 
Close-up images at an earlier time point such as 2 weeks demonstrated some 
remnant NP even in the untreated group, although the core of NP was already replaced 
with fibrous tissue in this group. There was no reparative tissue observed that bridged 
the gap between both ends of disrupted annulus tissue at the site of the needle puncture.  
Therefore, the annular defects were persistent (Fig 4.4A, a).  In the acellular gel-
treated segments, there was more tissue at the outer part of the annular defects, but this 
did not display good integration with the host AF; these defects were not physically 
closed either (Fig 4.4B, b). In the cellular gel-treated segments, there was a fibrous 
patch that integrated outer ends of the disrupted annular fiber and thereby physically 
closed the annular defect, although no substantial tissue was observed inside the 
annular defect (Fig 4.4C, c). At 5 weeks, this fibrous cap accompanied with scattered 
fibrochondrocytes grew thicker and robustly closed the gap at the outer edge of 
annular defect (Fig 4.4D, d).  
In order to assess the fate of injected collagen gels, histological sections 
stained with Alcian blue were utilized at 2-week time point.  Our previous study 
demonstrated that Alcian blue stains the collagen gels mildly/moderately blue26. In the 
present study, both cellular and acellular group demonstrated several islets of 
amorphous matrix, which is consistent with remnant collagen gels, in the paravertebral 
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space (Fig 4.5). These islets in the cellular group, even at 2 weeks, were intensively 
reorganized by infiltration of fibroblastic host cells, and the implanted 
fibrochondrocytes with lacuna structure are also observed in the gel domain (Fig 4.5A-
C). In contrast, the acellular gels demonstrated a lower degree of host cell infiltration 
and no chondrocytic cells inside. No sign of inflammatory or foreign body reaction 
was visible in both groups (Fig 4.5D). 
4.5 Discussion 
The present study demonstrates the feasibility of disc component AF 
fibrochondrocytes to facilitate annular repair in a needle puncture model. Discs treated 
with AF cell-laden collagen gels had more significant retention of disc height, 
prevented further NP herniation as well as subsequent degeneration, and maintained 
physiological hydration of NP. 
Biological approaches to DDD have reached remarkable feats over the past 
decade.  Although cell-therapy focusing on NP regeneration has been well studied, 
whether at a clinical or preclinical stage, cell-based strategies are much less frequently 
employed to repair annular defects33,34.  Sato et al. demonstrated that allografted 
cultured AF cells produced hyaline-like cartilage in the AF and NP region, and that 
segments receiving AF cells seeded in an atelocollagen honeycomb-shaped scaffold 
better maintained disc height compared to segments receiving scaffolds alone or 
untreated segments. Our results support Sato et al.’s existing data on disc height 
restoration as well as the conclusion that addition of AF cells can prevent or slowdown 
disc degeneration after annular injury. One conflicting finding is that reparative 
processes observed in the present study’s cellular group after 2 weeks yielded more 
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fibrous tissues with fibrochondrocytic cells scattered throughout, in contrast to the 
hyaline-like cartilaginous tissues observed in Sat et al.’s study. However, as our 
previous study demonstrated the presence of similar tissues induced by collagen gels 
in the same in vivo settings26,27, these differences in phenotypic features of reparative 
tissues may be caused by a discrepancy in animal species, mode of annular injury, 
utilization of rigid scaffolds, or mode of cell administration.  
In the present study and our previous study, fibrous caps integrating with the 
host annulus fibrosis were detected at 5 weeks (but not 2 weeks) after injection of 
acellular gels26. Of note, the cellular group demonstrated fibrous caps beginning at 2 
weeks.  This cellular fibrous cap, which became thicker at 5 weeks, approximated the 
gap between ruptured inner annular fibers and thereby physically closed the annular 
defect, preventing further loss of NP. The early formation of reparative tissues in the 
present study can account for the intergroup difference in the time course of NP 
retention. Only the cellular group had a trend of improvement, halting deteriorations in 
NP size from 2 to 5 week and resulting in significant retention at 5 weeks compared to 
those of the puncture and acellular groups (Fig 4.3A). In addition, the puncture and 
acellular groups demonstrated significant loss of hydration from 2 to 5 weeks while 
the cellular group did not show this downward trend and maintained over 90 % of 
adjacent healthy NP (Fig 4.3B). Accordingly, these findings suggest that the addition 
of AF cells can accelerate gel-induced formation of a reparative, fibrous cap at an 
earlier phase, and can play an inhibitory role in the loss of hydrated tissues as well as 
the progression of disc degeneration after annular injury.   
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Successful annular repair can play an important role in primarily reducing the 
risk of reherniation and progressive disc degeneration after discectomy, but also in 
providing a solution to a common issue in biological NP treatments, employing 
transannular approaches.  Annular defect can emerge not only from discectomy or 
discography, but also from regenerative treatments for the NP that proceed 
transannularly35. Given the sensitivity of the AF, lesions from NP treatment can 
provoke further degeneration, inducing leakage of the delivered material and eventual 
failure of the regenerative treatment. In fact, a previous study demonstrated that 
injecting mesenchymal stem cells (MSCs) through the AF into the NP led to cell 
leakage and augmented osteophyte formation36. An injectable biomaterial that seals 
the defect and delivers the cells of tissue-repairing capability can offer a platform for 
biological annular repair and may significantly improve patient outcomes, when 
combined with emerging biological treatments for NP.  
That being said, there are limitations related to our rat-tail puncture model. 
Firstly, the relatively small size of discs inhibits the injection of the gels into annular 
defects, in opposition to the intradiscal pressure.  Therefore, the injected gels were 
placed at a superficial layer of AF sealing the entrance of the annular defect. 
Eventually, the potential for collagen gels to repair deeper layers of AF was not 
possible to study. Secondly, an 18G needle might be too big to induce clinically 
relevant annular defects in a tiny rat-tail IVD model, which is likely the reason we 
observed a substantial loss of NP even at earlier time points. Thirdly, it is unclear 
whether the described fibrous cap can mechanically compensate for the motion in 
human IVDs, which are exposed to much higher mechanical forces and different axial 
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loads.  Another limitation is the brevity of the experimental follow-up period. 
Although significant intergroup differences were observed at a 5-week time point with 
the cellular group having the best outcomes, a further follow-up is needed to elucidate 
longer-term durability of the cell-based treatment. Nonetheless, these limitations do 
not critically affect the major conclusion of our study.  
Finally, there are two main limitations associated with a decision to use young, 
athymic rats: (1) these rats cannot offer insight into how these gels will integrate into 
immuno-competent animals (although a current pilot study we are performing in 
healthy sheep suggests no presence of immune inflammatory response), and (2) the rat 
IVD segments are young and healthy, and thus have none of the deficits in endplate 
nutrition, proteoglycan and collagen type II content, hydration, etc., that we observe in 
clinically relevant forms of human DDD  and disc herniation—which limits any far 
reaching conclusions about gel performance in a degenerated disc segment.  However, 
in terms of the overall objective of this study, which was to compare cellular vs. 
acellular gel performance in vivo, our experimental conclusions remain valid, and the 
rat-tail is still a useful and cost effective screening model. 
Overall, the present study demonstrates the feasibility of AF cell-laden 
collagen gels to facilitate annular repair in a needle puncture rat-tail model. The 
cellular gels outperformed the acellular gels, having significantly greater retention of 
disc height, preventing further NP herniation as well as subsequent degeneration, and 
maintaining physiological hydration of remnant NP. A long-term follow up with 
sufficient sample size is needed to confirm these results and the in vivo durability of 
cell-based annular treatments.  
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Figure 4.1: Five-week outcome examples. Adjacent healthy discs and punctured but 
untreated segments served as a positive and negative control, respectively. The cellular 
gel outperformed the acellular gel and maintained disc height on X rays as well as 
signal intensity on MRI T2 mapping, which was corroborated by retention of NP 
tissues on histology. Disruption of the endplate was observed in the puncture group, 
but not in the treated segments. 
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Figure 4.2: Quantitative assessment of disc height. Only the cellular gels maintained 
significantly greater disc height than the punctured segment. Asterisks and stars 
denote significant intergroup difference (puncture vs AF cell-laden, p<0.05) and 
intragroup time-dependent difference (2 week vs 5 week in the puncture group, 
p<0.05), respectively.  
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Figure 4.3: NP voxel count (top), and NP T2 relaxation time (bottom). Average NP 
voxel counts of cellular gels were higher than those of acellular gels at all time points 
and statistical significance was achieved at 1 and 5 weeks. There was a significant 
difference in NP retention between the cellular and acellular groups at 5 weeks. Both 
cellular and acellular groups had significant retention of T2 relaxation time compared 
to the puncture only group. The cellular group had significantly higher NP hydration 
than the acellular group. The puncture and acellular groups demonstrated significant 
loss of hydration at 5 weeks, while the cellular group maintained over 90 % of 
adjacent healthy NP hydration.  Asterisk: untreated vs cellular, p<0.05; Cross: 
puncture and vs cellular and acellular, p<0.05; Star: intragroup time-dependent 
difference. 
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Figure 4.4: Histological images stained with Safranin O demonstrated retention of NP 
as well as reparative tissue at the site of annular defect. The punctured and untreated 
group demonstrated persistent annular defects without any sealing tissues, and thereby 
lost most of NP as early as 2 weeks (A, a). The segment treated with acellular gels 
demonstrated some reparative tissue that attached to the disrupted annulus fibers at the 
outer part of the defect (B, b). Unlike the other groups, the cellular group revealed 
reparative tissue closing the gap between disrupted fibers at 2 weeks (C, c) and more 
at 5 weeks (D, d). Bars = 500 / 50 µm (A-D, a-d). AF: annulus fibrosus; NP: nucleus 
pulposus; FC: fibrous cap. Black triangles denote the annular defect. 
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Figure 4.5: 2 weeks after injection, remnant gels were shown as amorphous matrices 
mildly stained by Alcian blue in the paravertebral space of AF cell-laden and acellular 
groups. AF cell-laden gels (A-C) showed the cells accompanied with lacunae in the 
gel domain, suggesting that the implanted AF fibrochondrocytes survived (black 
arrows), while acellular gels (D) have similar gel-like matrices but no substantial cells 
within. The gel reorganization process is more advanced in the AF cell-laden gels than 
the acellular gels, which may be attributed to the presence of implanted AF cells 
and/or host cell infiltration (this is observed with direct comparison between B and D 
at the same magnification). No sign of inflammatory or foreign body reaction was 
visible in either group. The squares in A and B are image B and C, respectively. Bar = 
1000 / 50 / 25 / 50 µm (A / B / C / D). AF: annulus fibrosus; NP: nucleus pulposus; 
UVB: upper vertebral body; LVB: lower vertebral body; CG: collagen gels; SC: scar 
tissue. Black triangles denote the annular defect.
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CHAPTER 5: 
Conclusions 
This dissertation establishes riboflavin crosslinked collagen as a novel, 
injectable method for the repair of annulus fibrosus defects in the IVD.  Use of 
collagen hydrogels in research applications is wide spread, but its use in orthopedic 
applications is limited.  Here, we have seen that collagen can be delivered to the AF 
for mechanical repair of a composite fibrous tissue (Chapter 2), while allowing for 
biological healing to begin at the defect site (Chapters 3 and 4).  While only one 
application is addressed in this dissertation, it sets the groundwork for the expansion 
of riboflavin crosslinked collagen to other application where injectablilty is required 
for delivery. 
5.1 From the In Vitro Studies 
 Chapter 2 explored the effect of AF repair with various collagen gel 
formulations and crosslinker concentrations on the effective mechanical properties of 
rat caudal IVDs.  Small and large defects were tested, with the motivation being 
diagnostic and surgical procedures, respectively.  All collagen gel formulations in 
small defects outperformed their counterparts in larger defects.  Gross examination as 
well as histology confirmed gels at the defect site post-mechanical testing in both 
small and large defect samples. 
Changing collagen density or riboflavin concentration had positive effects on 
the repair of AF defects, with density having the most profound impacts on 
performance.  Small defects treated with the highest density, 15 mg/ml, showed 
significant differences from the untreated values for modulus and permeability.  All 
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riboflavin concentrations tested showed similar results for small AF defects, with 
profound improvements in effective disc permeability.  However, repair of larger 
defects gave mixed results, with many of the riboflavin concentrations having little 
effect on modulus and permeability. 
While the mechanical tests preformed in this study allowed us to quickly and 
effectively evaluate different formulations for collagen gel-based AF repair, what we 
observed in the data have greater implications for the mechanical evaluation of repair 
of the intervertebral disc.  As we touched on in the introduction, the correct 
mechanical function of the IVD is contingent upon having both AF and NP structures 
healthy.  With loss of or injury to one, we can expect this mechanical function of the 
full IVD to be diminished.  The most intuitive metric for assessing the mechanical 
integrity of a structure is often its stiffness, or modulus.  Indeed, there have been many 
instances of reporting stiffness of the AF, NP or whole IVD when assessing a 
treatment option or replacement23,30,116,118–120.  Assessing two types of moduli with 
small focal disc damage yielded little difference between the undamaged and damaged 
cases, which was unexpected.  After introducing even a small defect to a structure that 
is under pressure, like a balloon, one would expect a significant change in the 
compressive resistance.  However changes in moduli between undamaged, damaged 
and filled cases were insignificant.  Once a large, full disc height defect was 
introduced, we observed dramatic decreases in moduli.  Changes in stiffness of the 
IVD seemed to be insensitive to small defects, even though small defects (~40% disc 
height) have been shown to eventually lead to full disc degeneration. 
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While the modulus does yield vital information about the mechanical behavior 
of the IVD, the composite, interdependent nature of the disc lead us to wonder if other 
mechanical metrics would be best suited to gauge AF repair.  We observed that 
perhaps the hydraulic permeability is more pertinent to effective IVD function and 
assessing AF repair.  In the case of small defects, wherein moduli did not change 
significantly, hydraulic permeability increased almost 4-fold over undamaged values.  
According to these data, even minimal damage to the AF has a profound effect on its 
ability to impede the flow of water out of the NP.  Mechanically, this effects the 
ability of the NP to pressurize against the AF, and may weaken the disc over the long 
term leading to a collapsed disc space.  Even more than the mechanical effects are the 
biological implications coupled with fluid flow and diffusion, which we will discuss in 
the coming sections. 
5.2 From the In Vivo Studies 
 Through the in vitro studies, we were able to identify effective collagen 
formulations to be tested in an in vivo rat tail model of degeneration. High-density 
collagen gels were injected into AF needle puncture defects in anesthetized athymic 
rats.  As common markers of degeneration, disc height and NP hydration were 
assessed over time.  In Chapter 3, the effect of riboflavin was tested, while in Chapter 
4 the use of primary AF cells was assessed. 
 In either case, the needle puncture model successfully induced degeneration in 
untreated rats.  Creation of a defect prompted an almost immediate loss of disc height, 
and loss of NP tissue as evidenced by a black disc space on MRIs.  We found that 
using a riboflavin-crosslinked collagen gel greatly improved both disc height and 
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nucleus hydration over uncrosslinked counterparts at five weeks post-injection.  
Radiological and histological findings supported the qualitative data, since crosslinked 
samples exhibited a nearly indistinguishable phenotype compared to a healthy IVD 
(Figure 3.2), including a well-hydrated NP. 
 A similar trend was observed in the cell-seeded collagen gels.  While both cell-
seeded and acellular gels maintained disc height and hydrated NP tissue as expected, 
samples treated with the cell-seeded gels exhibited higher DHI and NP hydration.  
Histological examination of the AF defect sites revealed a continuous fibrous cap 
between severed ends of the outer AF in samples treated with cell-seeded collagen 
gels at 5 weeks.  These data confirm that adding primary AF cells to the riboflavin 
crosslinked collagen gels enhanced repair of needle puncture AF defects. 
  The overall aim of the in vivo studies was to assess repair of the full disc by 
assessing the progression of disc degeneration.  Specifically, we were interested in the 
biological repair of the IVD since we addressed mechanical repair in the in vitro 
studies.  Like most biological tissues, AF repair is a multifaceted issue with interplay 
between structure, function and mechanism.  In assessing degeneration in a live 
animal, we endeavored to study an overall manifestation of these facets.  Perhaps the 
most telling data in these studies were the histological stains.  We observed a normal 
disc phenotype in treated samples in both in vivo studies, with quantitative data 
supporting the histology.  Upon further inspection, the site of treatment showed an 
unorganized fibrous cab that did not exactly match the alignment of native AF tissue  
(Figures 3.6 and 4.4).  Although this fibrous cap is connected to the surrounding native 
tissue, its dissimilar phenotype prompted us to question the nature of our repair. 
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 From the in vitro studies we observed that the most affected mechanical metric 
was effective hydraulic permeability, which is indicative of improved water retention 
with collagen gel repair.  Due to the avascular nature of the disc, osmotic and 
convective flows are responsible for nutrient transport, waste removal, cell signaling 
and a host of other mechanisms121.  Therefore, controlling the flow of water both to 
and from the NP would be essential to regaining full IVD function.  Histology from 
the in vivo studies shows an irregular fibrous cap on the outer AF defect, but lesions 
toward the inner AF.  Although the damage to the inner AF is still present, treated 
discs retained a healthier phenotype than untreated samples.  From these data, we can 
infer that having the cap on the outside may have had a more profound effect on fluid 
flow to and from the NP, which in turn helped prevent NP loss and maintained proper 
fluid movement. 
 Since fluid flow is so critical to proper IVD function, it makes sense that an 
effective AF repair strategy should focus on not only stiffness and strength of the AF 
and IVD as a whole, but also allowing for communication between IVD cells and the 
para-vertebral space.  Other studies have implicated IVD cell dysfunction, NP cells in 
particular, in playing a major role in the degenerative cascade2,30.  Many of the 
signaling pathways used in normal IVD function and degeneration are dependent on 
flow of soluble factors for cell signaling.  As we’ve shown, by restoring proper 
effective hydraulic permeability within the IVD we were able to retain a healthy disc 
even without full depth AF repair. 
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5.3 Next Steps 
 While the results the rat-tail studies outlined above are very encouraging, it 
only serves as a beginning.  One of the major limitations of these studies is the size of 
the rat AF.  The average disc height of the rat caudal IVD is 1.2 mm with a radial 
depth of less than 0.5 mm.  This only leaves a small contact area for the delivered gel 
to contact and integrate.  Furthermore, the disc space in live animals tends to collapse 
upon puncture, making delivery of the collagen gel more difficult, especially to the 
inner AF, which is apparent in histology (Figures 3.5 and 4.4). Moving to a larger 
animal model will allow for more precise delivery, more definitive gross examination, 
and higher degree of relation to human activity.  Other AF repair studies report 
changes with ovine and porcine AF repair models and our own preliminary 
experiments in ovine lumbar IVDs have confirmed larger defect creation and more 
definitive gel delivery. 
 The collagen gel used in these studies is highly tunable and can be changed to 
better fit the needs of larger IVDs.  Our studies in Chapter 2 explored a range of gel 
densities and riboflavin concentrations in the AF repair model.  While 15 mg/ml is 
considered high when dealing with this injectable gel, groups have shown that it is 
possible to increase the collagen density even more without jeopardizing 
injectability122.  Riboflavin is an effective in situ crosslinker, which was shown to 
most notably enhance the in vivo repair of damaged intervertebral discs.  However, 
greater concentrations can be used to further enhance the mechanical properties of 
these high-density collagen gels (Appendix A).   
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Additionally, more should be done to enhance integration with surrounding 
tissue.  Incorporation of cells to the injectable gel increased fibrous cap tissue density 
and cell density in the affected area, as expected, but we still observed a different 
phenotype at the repair site.  The use of growth factors, such as those already being 
studied for disc regeneration (e.g.TGF-β, OP-1, BMP-2)30,123, with younger cells or 
perhaps stem cells may encourage remodeling of the damaged site to a more native 
architecture.  The current studies on this are still young, but should be explored with 
an injectable therapeutic such as our collagen gel formulations. 
 With regards to annulus fibrosus repair, tissue engineered methods look to be 
the next wave of therapies to work through the research and development pathway.  A 
gel, such as the one discussed in this thesis, would be the ideal option for repairing a 
wide range of AF defects, and may help open to door for delivering regenerative disc 
therapies.  With some further optimization, in situ-crosslinkable collagen gels could 
succeed in human AF repair, and be applied to a wider range of surgical applications 
in which such a solution is desperately needed. 
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APPENDIX A 
Effects of Riboflavin Crosslinking on High Density Collagen gels 
A.1 Introduction 
The previously discussed aims revolved around the use of riboflavin as a 
crosslinker in high-density collagen hydrogels for annulus fibrosus repair.  While 
riboflavin has been shown to be an effective crosslinker, documentation of its 
structural and mechanical effects on high-density collagen hydrogels is wanting.  
Existing studies report only indirect evidence of enhanced mechanical properties 
through gel contraction assays while observing the behavior of cells in a low-density 
(<6 mg/ml) collagen environment.  In an effort to specialize our injectable collagen, 
and develop a standardized method of formation, we investigated the effects of 
riboflavin crosslinking on the structural and mechanical properties of high-density 
collagen hydrogels. 
A.2 Methods for Collagen Gel Fabrication and Analysis 
Collagen Gels 
Rat tail tendon fibers were harvested from young Sprague Dawley rat tails 
(BioReclamation IVT, Long Island, NY) and suspended in a 0.1% acetic acid at 150 
ml/g.  After 48 hours, the soluble collagen was suspended in the acetic acid solution 
creating a semi-translucent tendon mix.  This mix was then centrifuged at 300xg for 
90 minutes, kept at 4°C during the entire process.  The resulting supernatant was 
collected, frozen and lyophilized for at least 48 hours.  Once all water was removed, 
the pure collagen was then resuspended in 0.1% acetic acid at the desired stock 
solution concentration, which should be higher than the intended testing concentration.  
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To ensure a fully dissolved mixture, the collagen was shaken by hand for at least 30 
seconds, twice per day.  The reconstituted stock collagen was stored at 4°C.   
In order to re-polymerize the collagen for use, it must be mixed with a working 
solution to neutralize the pH and normalize the osmolarity.  Working solutions 
containing 10x Dulbecco’s Phosphate Buffered Saline (DPBS), 1N NaOH and 1x 
DPBS were then mixed with stock collagen to create final collagen gels.  The 
incorporation of riboflavin into these gels is done during this mixing stage.  Before 
mixing the working solution components together, riboflavin was be added to the 1x 
DPBS at the desired concentration.  This ensured that the riboflavin is mixed directly 
into the collagen, with the intent of maximizing crosslinks within the gel.  With the 
stock and working solutions ready, they were mixed together using a two-
syringe/stopcock setup making sure a well-mixed homogenous solution was the result.  
The final collagen mix can was then injected onto a surface for testing or into the 
defect site for animal studies. 
For the purposes of crosslinking, riboflavin is sensitive to UVA/B light as well 
as blue wavelength visible light.  Blue wavelength light is an attractive option for 
biological applications, as it is not cytotoxic at the levels needed to induce 
crosslinking.  After injecting the mixed collagen into the desired location, the gel was 
exposed to blue light to accelerate crosslinking.  Our studies employed a dental curing 
light for tooth whitening, which is a diode that emits between 450 and 500nm 
wavelengths.  Each gel was exposed to a blue curing light (Spring Health Products, 
Norristown, PA) at 465nm and ~1200 mW/cm2 for 40 seconds.  The gels were then 
allowed to polymerize at room temperature for 30 minutes.   
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FITC-Labeling of Collagen 
To investigate microstructure via confocal microscope, rat tail tendon collagen 
can be labeled with fluorescein isothiocyanate (FITC) following a modified labeling 
protocol for protein labeling.  After lyophilizing collagen, the mass was resuspended 
in 1 N sodium bicarbonate at 2mg/ml and stirred at 4°C.  FITC (Sigma Aldrich, St. 
Louis, MO) was dissolved in dimethyl sulfoxide (DMSO) (Sigma Aldrich, St. Louis, 
MO) at 1 mg/ml and added to the stirring collagen mixture at a ratio of 3:1 
(FITC:collagen dry weight).  The resulting mixture was allowed to react for 48 hours 
before dialysis against 0.1% acetic acid for another 48 hours. 
A.3 Methods for testing and analysis 
Confocal Microscopy 
Biopsy punches (6 mm diameter) were taken from FITC labeled collagen sheet 
gels for microscopy on a Zeiss 710 inverted confocal microscope (Zeiss, Germany).  
All gels were imaged at various locations in the sample over a 63x oil-immersion 
objective lens.  Excitation was achieved using a 488 laser with emission recorded 
between 500-540 nm. 
Mechanical Testing 
Dogbone punches were taken from polymerized collagen sheet gels for tensile 
testing (gauge LxW at 5x5 mm).  Each sample was loaded into a uniaxial load fame 
(Bose Enduratec ELF3200, Eden Prarie, MN) using custom grips, and tested at 3% 
strain/s until failure.  Load data was analyzed in excel for tensile modulus and ultimate 
tensile stress (UTS). 
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Cylindrical biopsy punches (6mm diameter) were used for confined 
compression testing.  Each sample was loaded into a custom pot and hydrated with 
DPBS.  Stress-relaxation testing was done to 30% strain in steps of 5% of initial 
height.  Using a custom MATLAB program, poroelastic model was fit to the resulting 
load data for the calculation of equilibrium/instantaneous moduli as well as hydraulic 
permeability. 
A.4 Expected Experimental Results 
High-density collagen gels were crosslinked with various concentrations of 
riboflavin, and the structural and mechanical effects were analyzed.  Confocal 
fluorescence microscopy revealed larger fibril formation with increased riboflavin 
concentration (Figure A.1).  In 10 mg/ml gels, we observed larger fibrils embedded in 
a matrix of smaller fibrils much like those seen at the uncrosslinked, 0.0mM 
concentration.  However in the higher density, 15 mg/ml gels exhibited more 
pronounced networks of interconnected fibrils (Figure A.2). 
Tensile testing revealed peaks in modulus and UTS of crosslinked collagen 
gels, with a shift in maxima observed between collagen densities (Figure A.3a&b).  In 
10 mg/ml collagen gels, tensile modulus reached a peak of 12 kPa at 0.03 mM 
riboflavin, while a similar peak of 14.5 kPa was observed at 0.3 mM in 15 mg/ml 
collagen.  Trends in UTS between collagen gel densities were the same as those 
observed in modulus, with peak values being 13 and 16 kPa in 10 and 15 mg/ml gels 
respectively. 
Equilibrium modulus reached 12 kPa at 0.03mM riboflavin in 10 mg/ml 
collagen, a significant 6 fold increase from uncrosslinked gels (p<0.05).  At higher 
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concentrations of riboflavin, the equilibrium modulus remained unchanged.  In 15 
mg/ml gels, equilibrium modulus significantly increased almost 10 fold over 
uncrosslinked counterparts to 22.5 kPa when crosslinked with 0.6 mM riboflavin 
(Figure A.4).  Instantaneous modulus in 10 mg/ml collagen exhibited an immediate 
rise to 100 kPa when crosslinked at 0.03mM riboflavin, but maintained this level at 
increasing levels of riboflavin.  However, 15 mg/ml collagen gels exhibited a more 
steady rise in instantaneous modulus, reaching 500 kPa when crosslinked at 1.0 mM 
riboflavin (p<0.05) (Figure A.5).  Hydraulic permeability decreased dramatically, by 
over an order of magnitude, once the gels were crosslinked with riboflavin.  This 
decrease was independent of riboflavin concentration, and significant in the 10 mg/ml 
collagen gels (p<0.05).  
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Figure A.1 Confocal fluorescence images of 10 mg/ml FITC-labeled collagen gel 
crosslinked with riboflavin. 
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Figure A.2 Confocal fluorescence images of 15 mg/ml FITC-labeled collagen gel 
crosslinked with riboflavin. 
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Figure A.3: Results of tensile data analysis showing (a) Young’s Modulus and (b) 
ultimate tensile strength (UTS).  Points not joined by letter are significantly different 
(p<0.05). 
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Figure A.4: Results of poroelastic fit for compressive data.  (a) Equilibrium modulus, 
(b) instantaneous modulus and (c) hydraulic permeability of crosslinked collagen gels.  
Points not joined by letter are significantly different (p<0.05).  
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APPENDIX B 
Statistical Methods and Considerations 
B.1 In Vitro Studies (Chapter 2) 
Objective 
 Our goals with these studies were to establish a mechanical model for in vitro 
AF repair that would allow us to quickly and effectively test multiple repair 
formulations, and report the effects of multiple different collagen formulations on AF 
repair though whole-IVD mechanics.  Collagen gel density as well as riboflavin 
crosslinker concentrations were varied during the studies.  The reported properties 
were effective equilibrium and instantaneous moduli, as well as hydraulic 
permeability, which were measured for each stage of mechanical testing. 
Study Design 
 This study was a multi-level hierarchal design, with repeated measures on a 
single sample, and different variables being tested (Figure B.1).  
 Each caudal rat tail motion segment contained one IVD with both of the adjacent 
vertebral bones.  The bones were secured in the load frame, allowing us to actuate 
only the IVD.  Each disc was tested in compression, first undamaged, then damaged, 
and finally treated.  Each undamaged case was physically the same, with the IVD 
unchanged from dissection.  The damaged case consisted of two possible scenarios, 
one small defect or one large defect.  Within each of these damaged cases, three 
different collagen densities (5, 10 and 15 mg/ml) were tested.  Once the performance 
of different collagen gel densities was recorded and analyzed, the riboflavin based 
studies were conducted using 15 mg/ml collagen gels containing various 
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concentrations of riboflavin (0.0, 0.03, 0.07, 0.10 mM).  The control (0.0mM) group 
was the same data as the 15 mg/ml collagen gel group in the previous study, shown on 
the same level in Figure B.1.  Due to variability in the healthy values between each 
individual sample, we chose to normalize mechanical measurements of each 
individual sample before statistical comparison, and report standard deviation.  As 
such, the reported data is shown as fractions of unity, which represents the healthy 
condition. 
Statistical Analyses 
 The hierarchal nature of the experimental design called for multiple different 
statistical analyses to answer questions at each stage of testing, and then comparison 
of different stages to draw conclusions about repair with varying formulations.  With 
some initial guidance from the Cornell Statistical Consulting Unit, we chose to address 
three areas of interest with our data.   The first question was of overall repair; was 
there a significant difference between damaged cases and treated cases?  Did treating 
the segments with high-density collagen positively affect IVD mechanical behavior?  
To assess this, we first tested pooled experimental data sets, with the variables being 
damage vs treatment using any collagen gel formulation.  This was carried out using 
the JMP (mixed model/two-way ANOVA) and Sigmaplot (two-way-ANOVA) 
statistical software packages.  With all samples listed, the two factors were presence of 
treatment (healthy/damaged/treated) and treatment type (all collagen densities and 
riboflavin concentrations).  No significant differences were observed among the 
treatment type groups, however the pooled data shoed significant differences between 
the presence of treatments. 
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 After evaluating overall treatment, the second and third questions were of 
specific formulation factors; collagen density and riboflavin concentration 
respectively.  We addressed each study separately, with a one-way ANOVA analysis 
on collagen densities: 0, 5, 10 and 15 mg/ml, and a separate one-way ANOVA for the 
riboflavin densities: 0, 0.03, 0.07, and 0.10 mM.  These analyses were on repeated 
measures with preliminary tests for normality and equal variance.  After, finding 
initial significance, Tukey-HSD was used for direct comparison between treatment 
groups with statistical significance at p<0.05. 
B.2 In Vivo Studies (Chapter 3 and 4) 
Purpose 
 Both in vivo studies looked to assess the extent of biological repair of the AF 
through established markers of IVD degeneration.  Caudal IVDs in live athymic rats 
were either punctured and left untreated, or punctured and immediately treated with 
one of many different treatments.  In the first in vivo studies, we were interested in the 
performance of uncrosslinked versus crosslinked collagen, with multiple different 
concentrations of the crosslinker riboflavin.  In the second in vivo study, we shifted the 
focus to the incorporation of cells.   The analyzed and reported quantitative metrics 
were disc height index (DHI), T2 relaxation time (Chapter 4) and Voxel counts. 
Study Design 
 To accurately evaluate the extent of repair, it was necessary to track the IVDs 
for a period of time via radiological assessments. Thus, all of the reported results time-
dependent, with final radiological (non-lethal) measures taken at different time points.  
Regardless of treatment time point “zero” was the initial operation.  With the 
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exception of histological samples, all rats were allowed to roam within cages under 
care of veterinary staff for up to 5 weeks, with additional time points taken at weeks 1 
and 2. 
Statistical Analyses 
 Due to the nature of the studies, comparisons occurred at between multiple 
treatments, at different timepoints and within a single timepoint.  For example, DHI at 
two weeks were compared between all different treatment groups, but the two week 
time points for the puncture control was also compared to the five week timepoint of 
the same treatment group.   The chapter 3 studies were analyzed in JMP using mixed 
model ANOVA, with nesting for the adjacent healthy controls for each sample.  
Chapter 4 studies were analyzed in the SPSS statistical software package using a 
generalized linear regression model, comparing normalized values for DHI, voxel 
count and T2 relaxation time. 
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Figure B.1: Schematic of hierarchal study design for the study described in Chapter 2.  
Each IVD was tested three times: once healthy, once damaged and then again treated.  
Two different types of damage were administered (small or large) and one of six 
different treatments (shown from damage levels with colored arrows).
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